NF‐κB as a regulator of cancer metastasis and therapy response: A focus on epithelial–mesenchymal transition

Metastasis of tumor cells is a complex challenge and significantly diminishes the overall survival and prognosis of cancer patients. The epithelial‐to‐mesenchymal transition (EMT) is a well‐known mechanism responsible for the invasiveness of tumor cells. A number of molecular pathways can regulate t...

Full description

Saved in:
Bibliographic Details
Published inJournal of cellular physiology Vol. 237; no. 7; pp. 2770 - 2795
Main Authors Mirzaei, Sepideh, Saghari, Sam, Bassiri, Farzaneh, Raesi, Rasoul, Zarrabi, Ali, Hushmandi, Kiavash, Sethi, Gautam, Tergaonkar, Vinay
Format Journal Article
LanguageEnglish
Published United States Wiley Subscription Services, Inc 01.07.2022
Subjects
Breast
Cancer
cancer therapy
chemoresistance
Chemotherapy
Drug resistance
EMT
Gastric cancer
Growth factors
Invasiveness
Medical prognosis
Mesenchyme
Metastases
Metastasis
NF‐κB signaling
Nuclear transport
Translocation
Tumor cells
Tumors
Vimentin
NF-κB signaling
cancer therapy
chemoresistance
metastasis
EMT
Online AccessGet full text

Cover

Abstract Metastasis of tumor cells is a complex challenge and significantly diminishes the overall survival and prognosis of cancer patients. The epithelial‐to‐mesenchymal transition (EMT) is a well‐known mechanism responsible for the invasiveness of tumor cells. A number of molecular pathways can regulate the EMT mechanism in cancer cells and nuclear factor‐kappaB (NF‐κB) is one of them. The nuclear translocation of NF‐κB p65 can induce the transcription of several genes involved in EMT induction. The present review describes NF‐κB and EMT interaction in cancer cells and their association in cancer progression. Due to the oncogenic role NF‐κB signaling, its activation enhances metastasis of tumor cells via EMT induction. This has been confirmed in various cancers including brain, breast, lung and gastric cancers, among others. The ZEB1/2, transforming growth factor‐β, and Slug as inducers of EMT undergo upregulation by NF‐κB to promote metastasis of tumor cells. After EMT induction driven by NF‐κB, a significant decrease occurs in E‐cadherin levels, while N‐cadherin and vimentin levels undergo an increase. The noncoding RNAs can potentially also function as upstream mediators and modulate NF‐κB/EMT axis in cancers. Moreover, NF‐κB/EMT axis is involved in mediating drug resistance in tumor cells. Thus, suppressing NF‐κB/EMT axis can also promote the sensitivity of cancer cells to chemotherapeutic agents. The aim of the present review was to establish that how nuclear factor‐kappaB (NF‐κB) signaling can promote tumor progression via its impact on epithelial‐to‐mesenchymal transition (EMT) mechanism. The NF‐κB/EMT axis was found to be not only involved in increasing metastasis of tumor cells but also can mediate drug resistance and stemness of tumors.
AbstractList Metastasis of tumor cells is a complex challenge and significantly diminishes the overall survival and prognosis of cancer patients. The epithelial‐to‐mesenchymal transition (EMT) is a well‐known mechanism responsible for the invasiveness of tumor cells. A number of molecular pathways can regulate the EMT mechanism in cancer cells and nuclear factor‐kappaB (NF‐κB) is one of them. The nuclear translocation of NF‐κB p65 can induce the transcription of several genes involved in EMT induction. The present review describes NF‐κB and EMT interaction in cancer cells and their association in cancer progression. Due to the oncogenic role NF‐κB signaling, its activation enhances metastasis of tumor cells via EMT induction. This has been confirmed in various cancers including brain, breast, lung and gastric cancers, among others. The ZEB1/2, transforming growth factor‐β, and Slug as inducers of EMT undergo upregulation by NF‐κB to promote metastasis of tumor cells. After EMT induction driven by NF‐κB, a significant decrease occurs in E‐cadherin levels, while N‐cadherin and vimentin levels undergo an increase. The noncoding RNAs can potentially also function as upstream mediators and modulate NF‐κB/EMT axis in cancers. Moreover, NF‐κB/EMT axis is involved in mediating drug resistance in tumor cells. Thus, suppressing NF‐κB/EMT axis can also promote the sensitivity of cancer cells to chemotherapeutic agents.
Metastasis of tumor cells is a complex challenge and significantly diminishes the overall survival and prognosis of cancer patients. The epithelial‐to‐mesenchymal transition (EMT) is a well‐known mechanism responsible for the invasiveness of tumor cells. A number of molecular pathways can regulate the EMT mechanism in cancer cells and nuclear factor‐kappaB (NF‐κB) is one of them. The nuclear translocation of NF‐κB p65 can induce the transcription of several genes involved in EMT induction. The present review describes NF‐κB and EMT interaction in cancer cells and their association in cancer progression. Due to the oncogenic role NF‐κB signaling, its activation enhances metastasis of tumor cells via EMT induction. This has been confirmed in various cancers including brain, breast, lung and gastric cancers, among others. The ZEB1/2, transforming growth factor‐β, and Slug as inducers of EMT undergo upregulation by NF‐κB to promote metastasis of tumor cells. After EMT induction driven by NF‐κB, a significant decrease occurs in E‐cadherin levels, while N‐cadherin and vimentin levels undergo an increase. The noncoding RNAs can potentially also function as upstream mediators and modulate NF‐κB/EMT axis in cancers. Moreover, NF‐κB/EMT axis is involved in mediating drug resistance in tumor cells. Thus, suppressing NF‐κB/EMT axis can also promote the sensitivity of cancer cells to chemotherapeutic agents.
Metastasis of tumor cells is a complex challenge and significantly diminishes the overall survival and prognosis of cancer patients. The epithelial-to-mesenchymal transition (EMT) is a well-known mechanism responsible for the invasiveness of tumor cells. A number of molecular pathways can regulate the EMT mechanism in cancer cells and nuclear factor-kappaB (NF-κB) is one of them. The nuclear translocation of NF-κB p65 can induce the transcription of several genes involved in EMT induction. The present review describes NF-κB and EMT interaction in cancer cells and their association in cancer progression. Due to the oncogenic role NF-κB signaling, its activation enhances metastasis of tumor cells via EMT induction. This has been confirmed in various cancers including brain, breast, lung and gastric cancers, among others. The ZEB1/2, transforming growth factor-β, and Slug as inducers of EMT undergo upregulation by NF-κB to promote metastasis of tumor cells. After EMT induction driven by NF-κB, a significant decrease occurs in E-cadherin levels, while N-cadherin and vimentin levels undergo an increase. The noncoding RNAs can potentially also function as upstream mediators and modulate NF-κB/EMT axis in cancers. Moreover, NF-κB/EMT axis is involved in mediating drug resistance in tumor cells. Thus, suppressing NF-κB/EMT axis can also promote the sensitivity of cancer cells to chemotherapeutic agents.Metastasis of tumor cells is a complex challenge and significantly diminishes the overall survival and prognosis of cancer patients. The epithelial-to-mesenchymal transition (EMT) is a well-known mechanism responsible for the invasiveness of tumor cells. A number of molecular pathways can regulate the EMT mechanism in cancer cells and nuclear factor-kappaB (NF-κB) is one of them. The nuclear translocation of NF-κB p65 can induce the transcription of several genes involved in EMT induction. The present review describes NF-κB and EMT interaction in cancer cells and their association in cancer progression. Due to the oncogenic role NF-κB signaling, its activation enhances metastasis of tumor cells via EMT induction. This has been confirmed in various cancers including brain, breast, lung and gastric cancers, among others. The ZEB1/2, transforming growth factor-β, and Slug as inducers of EMT undergo upregulation by NF-κB to promote metastasis of tumor cells. After EMT induction driven by NF-κB, a significant decrease occurs in E-cadherin levels, while N-cadherin and vimentin levels undergo an increase. The noncoding RNAs can potentially also function as upstream mediators and modulate NF-κB/EMT axis in cancers. Moreover, NF-κB/EMT axis is involved in mediating drug resistance in tumor cells. Thus, suppressing NF-κB/EMT axis can also promote the sensitivity of cancer cells to chemotherapeutic agents.
Metastasis of tumor cells is a complex challenge and significantly diminishes the overall survival and prognosis of cancer patients. The epithelial‐to‐mesenchymal transition (EMT) is a well‐known mechanism responsible for the invasiveness of tumor cells. A number of molecular pathways can regulate the EMT mechanism in cancer cells and nuclear factor‐kappaB (NF‐κB) is one of them. The nuclear translocation of NF‐κB p65 can induce the transcription of several genes involved in EMT induction. The present review describes NF‐κB and EMT interaction in cancer cells and their association in cancer progression. Due to the oncogenic role NF‐κB signaling, its activation enhances metastasis of tumor cells via EMT induction. This has been confirmed in various cancers including brain, breast, lung and gastric cancers, among others. The ZEB1/2, transforming growth factor‐β, and Slug as inducers of EMT undergo upregulation by NF‐κB to promote metastasis of tumor cells. After EMT induction driven by NF‐κB, a significant decrease occurs in E‐cadherin levels, while N‐cadherin and vimentin levels undergo an increase. The noncoding RNAs can potentially also function as upstream mediators and modulate NF‐κB/EMT axis in cancers. Moreover, NF‐κB/EMT axis is involved in mediating drug resistance in tumor cells. Thus, suppressing NF‐κB/EMT axis can also promote the sensitivity of cancer cells to chemotherapeutic agents. The aim of the present review was to establish that how nuclear factor‐kappaB (NF‐κB) signaling can promote tumor progression via its impact on epithelial‐to‐mesenchymal transition (EMT) mechanism. The NF‐κB/EMT axis was found to be not only involved in increasing metastasis of tumor cells but also can mediate drug resistance and stemness of tumors.
Author Tergaonkar, Vinay
Raesi, Rasoul
Sethi, Gautam
Mirzaei, Sepideh
Saghari, Sam
Bassiri, Farzaneh
Hushmandi, Kiavash
Zarrabi, Ali
Author_xml – sequence: 1
  givenname: Sepideh
  surname: Mirzaei
  fullname: Mirzaei, Sepideh
  organization: Islamic Azad University
– sequence: 2
  givenname: Sam
  surname: Saghari
  fullname: Saghari, Sam
  organization: Islamic Azad University
– sequence: 3
  givenname: Farzaneh
  surname: Bassiri
  fullname: Bassiri, Farzaneh
  organization: Islamic Azad University
– sequence: 4
  givenname: Rasoul
  surname: Raesi
  fullname: Raesi, Rasoul
  organization: Mashhad University of Medical Sciences
– sequence: 5
  givenname: Ali
  orcidid: 0000-0003-0391-1769
  surname: Zarrabi
  fullname: Zarrabi, Ali
  organization: Istinye University
– sequence: 6
  givenname: Kiavash
  surname: Hushmandi
  fullname: Hushmandi, Kiavash
  email: Kiavash.hushmandi@gmail.com
  organization: University of Tehran
– sequence: 7
  givenname: Gautam
  orcidid: 0000-0002-8677-8475
  surname: Sethi
  fullname: Sethi, Gautam
  email: phcgs@nus.edu.sg
  organization: National University of Singapore
– sequence: 8
  givenname: Vinay
  surname: Tergaonkar
  fullname: Tergaonkar, Vinay
  email: vinayt@imcb.a-star.edu.sg
  organization: National University of Singapore
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35561232$$D View this record in MEDLINE/PubMed
BookMark eNp90c1u1DAQAGALtaLbhQMvgCxxoYe0_omTmFtZtUBVAQc4R449oV45dmonQnvrIyDxNjwED9Enwcu2PVQCydJInm9Go5lDtOeDB4ReUHJMCWEnaz0ec1IL-QQtKJF1UVaC7aFFztFCipIeoMOU1oQQKTl_ig64EBVlnC3Q9cfz25sfv3-9xSphhSN8m52aQsShx1p5DREPMKmUn83AGzxdQVTjJtM0Bp_gDT7FfdBzwsFjGG3OO6vc7c3PARJ4fbUZlMNTVD7ZyQb_DO33yiV4fheX6Ov52ZfV--Ly07sPq9PLQnPBZVHVIHljekG7klc96yXI7V9nSsVkU5lac2OgVpJBZ3pWM94oCgZEJTtVUr5Er3d9xxiuZ0hTO9ikwTnlIcypZVVV1lIIzjN99Yiuwxx9ni6rphElr_NMS_TyTs3dAKYdox1U3LT3y8zgaAd0DClF6B8IJe32UG0-VPv3UNmePLLaTmq7n7wp6_5X8d062Py7dXux-ryr-AOyiqcH
CitedBy_id crossref_primary_10_1002_kjm2_12924
crossref_primary_10_1210_endocr_bqad026
crossref_primary_10_1016_j_biopha_2024_116685
crossref_primary_10_1186_s12885_025_13720_0
crossref_primary_10_1016_j_chmed_2025_01_007
crossref_primary_10_1016_j_lfs_2022_120984
crossref_primary_10_3390_cancers14204978
crossref_primary_10_3390_ijms252212408
crossref_primary_10_1007_s10528_024_10844_z
crossref_primary_10_1016_j_scib_2024_03_056
crossref_primary_10_1039_D4SC01469C
crossref_primary_10_1248_bpb_b23_00256
crossref_primary_10_1016_j_heliyon_2024_e27184
crossref_primary_10_1186_s13578_024_01301_w
crossref_primary_10_1097_MD_0000000000036467
crossref_primary_10_1002_mc_23854
crossref_primary_10_1016_j_phrs_2022_106553
crossref_primary_10_18632_aging_205540
crossref_primary_10_37349_etat_2024_00218
crossref_primary_10_1016_j_yexcr_2023_113650
crossref_primary_10_3390_ijms242216221
crossref_primary_10_1007_s10620_024_08375_z
crossref_primary_10_1111_jdi_70025
crossref_primary_10_1016_j_intimp_2023_110876
crossref_primary_10_1038_s41598_023_49156_4
crossref_primary_10_1186_s13062_024_00513_x
crossref_primary_10_3892_mmr_2024_13379
crossref_primary_10_1016_j_biopha_2024_116979
crossref_primary_10_1007_s10555_023_10134_x
crossref_primary_10_1016_j_bbamcr_2024_119785
crossref_primary_10_37349_ei_2025_1003187
crossref_primary_10_1016_j_prp_2024_155484
crossref_primary_10_3389_fonc_2023_1256537
crossref_primary_10_1002_mnfr_202400387
crossref_primary_10_1007_s12672_025_01818_7
crossref_primary_10_1016_j_heliyon_2024_e40267
crossref_primary_10_1007_s11010_023_04886_x
crossref_primary_10_1016_j_isci_2025_111765
crossref_primary_10_1093_hmg_ddae001
crossref_primary_10_1111_jcmm_18173
crossref_primary_10_1016_j_lfs_2023_121458
crossref_primary_10_46879_ukroj_4_2024_459_477
crossref_primary_10_3390_kinasesphosphatases2010002
crossref_primary_10_1016_j_biopha_2023_114758
crossref_primary_10_1007_s00204_022_03421_z
crossref_primary_10_1038_s41598_025_85241_6
crossref_primary_10_3892_ol_2024_14691
crossref_primary_10_3390_cancers17020228
crossref_primary_10_1016_j_envres_2024_120293
crossref_primary_10_3389_fimmu_2024_1361606
crossref_primary_10_3390_cells11193106
crossref_primary_10_3390_genes13122375
crossref_primary_10_1016_j_clinsp_2023_100276
crossref_primary_10_1016_j_yexcr_2024_114101
crossref_primary_10_1016_j_biopha_2024_117483
crossref_primary_10_1142_S0192415X24500964
crossref_primary_10_3389_fimmu_2023_1209947
crossref_primary_10_3389_fonc_2023_1192482
crossref_primary_10_1186_s43556_024_00188_w
crossref_primary_10_1038_s41556_024_01428_5
crossref_primary_10_1080_14728222_2023_2225767
crossref_primary_10_1016_j_csbj_2024_12_020
crossref_primary_10_1016_j_heliyon_2024_e24405
crossref_primary_10_1093_biomethods_bpaf007
crossref_primary_10_3897_pharmacia_72_e146759
crossref_primary_10_2174_0109298673281823231222065616
crossref_primary_10_3390_ijms24119236
crossref_primary_10_1002_ptr_8352
crossref_primary_10_1186_s12943_023_01922_8
crossref_primary_10_3390_biom12091185
crossref_primary_10_1186_s11658_023_00448_7
crossref_primary_10_3802_jgo_2022_33_e74
crossref_primary_10_1007_s11033_024_09447_z
crossref_primary_10_70749_ijbr_v3i2_713
crossref_primary_10_3389_fnut_2023_1284985
crossref_primary_10_1016_j_arr_2024_102576
crossref_primary_10_1016_j_archoralbio_2024_106068
crossref_primary_10_1111_imm_13699
crossref_primary_10_3892_or_2022_8425
crossref_primary_10_1016_j_cellsig_2022_110433
crossref_primary_10_1007_s10555_025_10240_y
crossref_primary_10_1016_j_phytol_2022_10_001
crossref_primary_10_3390_ph16121675
crossref_primary_10_7554_eLife_79655
crossref_primary_10_1007_s00210_024_03647_x
crossref_primary_10_3390_ph16020160
crossref_primary_10_3390_biomedicines11061611
crossref_primary_10_3390_ijms241310592
crossref_primary_10_1186_s40170_024_00347_1
crossref_primary_10_3390_ijms24031823
crossref_primary_10_1186_s12575_023_00228_9
crossref_primary_10_1021_acs_jmedchem_4c00202
crossref_primary_10_1016_j_crphar_2023_100167
crossref_primary_10_1186_s13046_024_03206_5
crossref_primary_10_1016_j_canlet_2024_217098
crossref_primary_10_2147_DDDT_S489092
crossref_primary_10_3390_pharmaceutics15020712
crossref_primary_10_1016_j_isci_2025_111843
crossref_primary_10_1371_journal_pntd_0012545
crossref_primary_10_1016_j_prp_2023_154442
crossref_primary_10_1016_j_tranon_2023_101670
crossref_primary_10_3389_fcell_2025_1521151
crossref_primary_10_1016_j_intimp_2024_112821
crossref_primary_10_1002_mnfr_202300793
crossref_primary_10_1016_j_biopha_2022_113951
crossref_primary_10_1016_j_bbamcr_2022_119344
crossref_primary_10_3390_cells13131091
crossref_primary_10_1016_j_tifs_2024_104398
crossref_primary_10_1007_s40618_025_02531_6
crossref_primary_10_1016_j_fitote_2023_105617
crossref_primary_10_3390_ijms232012380
crossref_primary_10_1016_j_cellsig_2023_110610
crossref_primary_10_3390_diagnostics15060652
crossref_primary_10_3390_app14198768
crossref_primary_10_3892_ol_2024_14410
crossref_primary_10_1016_j_gendis_2024_101330
crossref_primary_10_1016_j_gene_2024_149000
crossref_primary_10_1093_jpp_rgae045
crossref_primary_10_1016_j_phrs_2022_106535
crossref_primary_10_1186_s13058_023_01652_1
crossref_primary_10_1166_jbn_2024_3738
crossref_primary_10_3390_biom14030342
crossref_primary_10_3724_abbs_2024186
crossref_primary_10_1186_s13027_024_00609_z
crossref_primary_10_1016_j_bbrc_2024_150143
crossref_primary_10_3103_S0095452724050086
crossref_primary_10_3390_cancers15133338
crossref_primary_10_3390_cancers14215237
crossref_primary_10_3390_ijms241813985
crossref_primary_10_20517_2394_4722_2024_77
crossref_primary_10_18632_aging_205696
crossref_primary_10_1016_j_jma_2025_02_010
crossref_primary_10_3390_molecules30020294
Cites_doi 10.1016/j.molimm.2020.11.016
10.1016/j.phrs.2021.105759
10.3390/biom11060893
10.1016/j.canlet.2021.03.018
10.3390/antiox10030349
10.1080/10799893.2020.1808679
10.1038/s41419-021-03929-9
10.18632/aging.102644
10.1016/j.biopha.2020.111077
10.2147/dddt.S269901
10.3390/cancers12082203
10.1016/j.bbcan.2020.188423
10.3390/biomedicines9091265
10.1158/1940-6207.Capr-13-0070
10.1186/s12885-017-3829-9
10.1016/j.ijbiomac.2021.04.185
10.1016/j.canlet.2010.03.003
10.18632/oncotarget.2881
10.1158/1538-7445.AM2016-1741
10.3389/fchem.2020.00829
10.1007/s13277-015-3687-5
10.1007/s12094-021-02594-w
10.3389/fphar.2018.00365
10.1016/j.tranon.2021.101160
10.3390/ijms21114002
10.1080/03008207.2019.1702650
10.1038/sj.onc.1209808
10.1002/jcp.30561
10.1186/s13046-018-0953-6
10.1080/19336918.2016.1259058
10.1007/s13577-021-00603-2
10.1038/s41419-020-03257-4
10.7717/peerj.9559
10.1007/s11523-016-0452-7
10.3390/cells10123348
10.18632/oncotarget.23645
10.1111/cpr.13143
10.1016/j.lfs.2021.119649
10.3389/fonc.2021.683878
10.3390/biomedicines6030082
10.3892/or.2018.6348
10.1002/jcp.29327
10.1186/s12935-020-01349-x
10.4062/biomolther.2020.200
10.1007/s00204-015-1470-4
10.1016/j.lfs.2021.119368
10.1007/s13277-014-2899-4
10.18632/oncotarget.3956
10.1016/j.bbrc.2020.07.015
10.3390/ijms18091833
10.3892/ijo.2013.1852
10.1016/j.canlet.2017.11.037
10.1002/jcb.29951
10.1038/s41467-020-20664-5
10.1155/2021/8851763
10.1016/j.ejphar.2020.173493
10.1111/jcmm.16536
10.1111/jcmm.13602
10.1016/j.omto.2021.01.005
10.1016/j.yexcr.2020.112157
10.1016/j.scitotenv.2021.147990
10.1016/j.mvr.2019.103968
10.1007/s00018-019-03053-0
10.3390/molecules26082382
10.1038/sj.onc.1210544
10.1080/13880209.2019.1701044
10.3892/ijo.2018.4543
10.1016/j.canlet.2021.03.025
10.1007/s12079-020-00589-w
10.1016/j.bmc.2018.12.042
10.3390/biom10101374
10.1016/j.cellsig.2021.109927
10.1038/bjc.2014.422
10.2147/dddt.S272323
10.1007/s10911-018-9404-4
10.1016/j.ejphar.2021.174344
10.1186/s13046-020-01553-7
10.1016/j.bbamcr.2018.01.006
10.18632/oncotarget.20418
10.1245/s10434-018-07132-7
10.3390/ijms22115543
10.3892/ijo.2018.4295
10.3892/or.2021.8066
10.3892/etm.2020.8752
10.1016/j.canlet.2018.05.038
10.1007/s11010-020-03986-2
10.1016/j.ijbiomac.2021.02.202
10.1016/j.lfs.2020.119005
10.3389/fphar.2018.01125
10.3390/cells8101178
10.1096/fj.06-7615rev
10.3390/biomedicines9091278
10.3390/molecules24081584
10.3892/or.2016.5319
10.1111/cpr.12776
10.1089/ars.2015.6418
10.1016/j.cellsig.2020.109871
10.1016/j.bbrc.2018.03.071
10.1016/j.molmed.2017.11.003
10.1038/s41419-018-0414-3
10.1186/s12943-016-0564-9
10.2174/1568009621666210601114631
10.1016/j.canlet.2018.06.008
10.1371/journal.pone.0169622
10.3892/or.2020.7891
10.1038/srep27331
10.3390/ijms20030749
10.3390/cancers13205135
10.1016/j.semcancer.2021.07.015
10.1002/med.21761
10.2174/1871520620666200811113549
10.1016/j.canlet.2020.04.023
10.1016/j.biopha.2020.111214
10.1002/ptr.7305
10.3390/biom9070262
10.1016/j.phrs.2021.105575
10.1016/j.phymed.2021.153492
10.3892/ijo.2015.3256
10.1186/s13578-021-00677-3
10.1002/cam4.1076
10.1016/j.lfs.2020.117967
10.3390/biom10081159
10.3892/ol.2019.11090
10.1182/blood-2007-04-084996
10.1039/c6fo01588c
10.1002/ptr.6815
10.3892/or.2020.7801
10.1007/s11033-018-4479-y
10.1016/j.biopha.2020.110869
10.3389/fphar.2021.758219
10.3390/biomedicines8080264
10.1186/s12935-021-01773-7
10.1016/j.cyto.2021.155433
10.1007/s11010-019-03514-x
10.26355/eurrev_202002_20172
10.1042/bsr20190452
10.1016/j.ccr.2021.214135
10.1016/j.jgr.2017.03.008
10.1016/j.febslet.2008.04.046
10.3390/molecules25030689
10.1111/j.1600-065X.2012.01099.x
10.1042/bsr20190724
10.1093/jnci/djw278
10.3390/cancers13184510
10.1016/j.fct.2021.112576
10.1021/acsomega.1c03477
10.1074/jbc.M601162200
10.7150/jca.59747
10.1016/j.bbcan.2018.10.004
10.1016/j.lfs.2021.119948
10.3390/nu10050645
10.4149/neo_2021_201031N1158
10.1038/s41388-020-01635-y
10.1002/jcb.27535
10.1016/j.canlet.2014.08.002
10.1016/j.ejphar.2020.173660
10.1155/2019/2474805
10.18632/aging.104184
10.2174/1871520620666200228110704
10.3390/cancers13071602
10.18632/aging.102598
10.1016/j.bbcan.2010.01.002
10.3390/ijms222111669
10.1111/jcmm.14574
10.1016/j.lfs.2020.119006
10.1080/15384047.2015.1028702
10.1016/0003-9969(76)90001-7
10.1016/j.lfs.2021.119430
10.1080/01635581.2019.1675722
10.1111/cas.14648
10.3390/molecules25102396
10.3892/or.2016.4927
10.1016/j.febslet.2015.02.035
10.3727/096504016x14799180778233
10.3389/fphar.2016.00395
10.1016/j.lfs.2020.117973
10.1016/j.fct.2018.12.009
10.33594/000000084
10.1093/jb/mvz062
10.1016/j.phrs.2020.105159
10.1007/s13577-016-0157-3
10.1002/mc.22166
10.1038/s41420-018-0026-9
10.1097/cad.0000000000000211
10.3892/or.2020.7523
10.1016/j.bbrc.2020.03.091
10.3390/biomedicines9080889
10.1016/j.bbcan.2018.10.002
10.3390/biology9060126
10.1016/j.biocel.2019.01.003
10.1007/s11033-021-06173-8
10.1016/j.biopha.2021.112335
10.1016/j.bbrc.2015.07.004
10.7150/ijbs.58062
10.1002/jcp.30590
10.3390/antiox6010017
10.1002/mc.22471
10.1007/s12032-015-0564-4
10.1016/j.ejphar.2020.173226
10.1038/s41598-018-20724-3
10.1038/s41388-021-02067-y
10.1016/j.ijbiomac.2021.09.089
10.1016/j.semcancer.2019.08.014
10.1016/j.biopha.2017.04.001
10.1016/j.bcp.2007.10.010
10.3390/biom11010015
10.1038/s41388-019-0848-9
10.3892/ol.2018.8230
10.1038/leu.2013.200
10.1007/s00210-019-01671-w
10.1136/gutjnl-2020-322980
10.2147/ott.S220306
10.1002/jso.24348
10.1016/j.phrs.2019.104504
10.3892/or.2017.5524
10.1177/0300060521992900
10.1371/journal.pone.0153155
10.7150/thno.26687
10.1016/j.bbcan.2020.188449
10.2174/1874467214666210203211312
10.1016/j.canlet.2015.03.019
10.1038/nri.2017.142
10.1002/hep.30917
10.3892/or.2020.7600
10.1016/j.bbrc.2020.01.166
10.18632/oncotarget.21170
10.1146/annurev-biophys-083012-130338
10.2174/1874467214666210120153348
10.18632/aging.202291
10.2174/1566524020666200521080953
10.3892/or.2017.5453
10.1080/2162402x.2017.1423170
10.1111/jcmm.17017
10.1155/2019/9241769
10.1002/ijc.31605
10.1002/jcb.27738
10.1016/j.carbpol.2021.117809
10.3892/ijmm.2018.3788
10.1002/ijc.26120
10.3390/ijms21145164
10.3390/biomedicines9080870
10.3389/fphar.2018.01294
10.1093/carcin/bgy178
10.1002/1878-0261.12623
10.1158/1078-0432.Ccr-11-2470
10.7150/ijbs.39582
10.1186/s12943-017-0688-6
10.1186/s12885-019-5945-1
10.1038/s41419-021-04346-8
10.1007/s11033-021-06268-2
10.1007/s00109-013-1095-0
10.1007/s12079-019-00522-w
10.3390/biom10071040
10.3390/cancers10120481
10.1016/j.cellsig.2021.110088
10.3389/fonc.2018.00042
10.1371/journal.pone.0158529
10.1016/j.lfs.2020.118372
10.1002/ijc.22657
10.1017/erm.2021.15
10.1016/j.bbrc.2018.08.005
10.1016/j.bcp.2010.07.045
10.1016/j.semcancer.2016.03.002
10.1111/jcmm.16079
10.3390/cancers13010130
10.1007/978-0-387-89520-8_3
10.1016/j.yexcr.2019.111785
10.1016/j.lfs.2019.117167
10.2174/1568009621666210203110305
10.1016/j.canlet.2015.03.033
10.1016/j.carbpol.2021.118491
10.3892/mmr.2021.12261
10.3892/or.2017.5369
10.1038/s41467-018-05644-0
10.1016/j.molmed.2016.03.002
10.3390/biom10010066
10.4149/bll_2020_005
10.1016/j.biopha.2021.111824
10.1038/s41467-019-13082-9
10.1097/cad.0000000000001022
10.1002/ctm2.233
10.21873/anticanres.14757
10.1002/ijc.23745
10.2147/jhc.S336858
10.1016/j.phrs.2019.104327
ContentType Journal Article
Copyright 2022 Wiley Periodicals LLC.
Copyright_xml – notice: 2022 Wiley Periodicals LLC.
DBID AAYXX
CITATION
NPM
7TK
7U7
8FD
C1K
FR3
K9.
P64
RC3
7X8
DOI 10.1002/jcp.30759
DatabaseName CrossRef
PubMed
Neurosciences Abstracts
Toxicology Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
ProQuest Health & Medical Complete (Alumni)
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
PubMed
Genetics Abstracts
Technology Research Database
Toxicology Abstracts
ProQuest Health & Medical Complete (Alumni)
Engineering Research Database
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList CrossRef
PubMed
Genetics Abstracts
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
Biology
EISSN 1097-4652
EndPage 2795
ExternalDocumentID 35561232
10_1002_jcp_30759
JCP30759
Genre reviewArticle
Journal Article
Review
GroupedDBID ---
-DZ
-~X
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
1L6
1OB
1OC
1ZS
31~
33P
36B
3O-
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52S
52T
52U
52W
52X
53G
5GY
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
85S
8UM
930
9M8
A03
AAESR
AAEVG
AAHHS
AAHQN
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABDPE
ABEFU
ABEML
ABIJN
ABJNI
ABPPZ
ABPVW
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFO
ACGFS
ACNCT
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFRAH
AFWVQ
AFZJQ
AHBTC
AHMBA
AIAGR
AITYG
AIURR
AIWBW
AJBDE
AJXKR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ATUGU
AUFTA
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMNLL
BMXJE
BNHUX
BQCPF
BROTX
BRXPI
BY8
CS3
D-E
D-F
DCZOG
DPXWK
DR1
DR2
DRFUL
DRSTM
DU5
EBD
EBS
EJD
EMB
EMOBN
F00
F01
F04
F5P
FEDTE
G-S
G.N
GNP
GODZA
H.T
H.X
HBH
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
H~9
IH2
IX1
J0M
JPC
KQQ
L7B
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M56
MEWTI
MK4
MRFUL
MRSTM
MSFUL
MSSTM
MVM
MXFUL
MXSTM
N04
N05
N9A
NEJ
NF~
NNB
O66
O9-
OHT
OIG
P2P
P2W
P2X
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RIWAO
ROL
RWI
RWR
RX1
RYL
S10
SAMSI
SUPJJ
SV3
TN5
TWZ
UB1
UPT
V2E
V8K
VQP
W8V
W99
WBKPD
WH7
WIB
WIH
WIK
WJL
WNSPC
WOHZO
WQJ
WRC
WXSBR
WYB
WYISQ
X7M
XG1
XJT
XOL
XPP
XSW
XV2
Y6R
YQT
YZZ
ZGI
ZXP
ZZTAW
~IA
~WT
AAYXX
ADXHL
AETEA
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
NPM
7TK
7U7
8FD
C1K
FR3
K9.
P64
RC3
7X8
ID FETCH-LOGICAL-c3539-67e938df51b436f2f9e967e9bd4a2986d7c3dde7a92ebdf27238a1ede569ba413
IEDL.DBID DR2
ISSN 0021-9541
1097-4652
IngestDate Thu Jul 10 18:08:27 EDT 2025
Fri Jul 25 21:33:15 EDT 2025
Mon Jul 21 05:46:28 EDT 2025
Tue Jul 01 03:23:46 EDT 2025
Thu Apr 24 23:09:57 EDT 2025
Wed Jan 22 16:25:46 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 7
Keywords NF-κB signaling
cancer therapy
chemoresistance
metastasis
EMT
Language English
License 2022 Wiley Periodicals LLC.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3539-67e938df51b436f2f9e967e9bd4a2986d7c3dde7a92ebdf27238a1ede569ba413
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ORCID 0000-0002-8677-8475
0000-0003-0391-1769
PMID 35561232
PQID 2688543735
PQPubID 1006363
PageCount 26
ParticipantIDs proquest_miscellaneous_2664795533
proquest_journals_2688543735
pubmed_primary_35561232
crossref_primary_10_1002_jcp_30759
crossref_citationtrail_10_1002_jcp_30759
wiley_primary_10_1002_jcp_30759_JCP30759
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate July 2022
PublicationDateYYYYMMDD 2022-07-01
PublicationDate_xml – month: 07
  year: 2022
  text: July 2022
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Hoboken
PublicationTitle Journal of cellular physiology
PublicationTitleAlternate J Cell Physiol
PublicationYear 2022
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References 2021; 69
2021; 68
2020; 20
2019; 10
2021; 447
2019; 13
2019; 12
2020; 161
2020; 16
2019; 19
2020; 14
2012; 18
2020; 13
2020; 12
2020; 11
2020; 10
2016; 37
2008; 582
2016; 36
2019; 166
2021; 70
2020; 19
2021; 78
2011; 129
2019; 20
2019; 24
2019; 23
2019; 26
2019; 27
2021; 790
2016; 40‐41
2021; 82
2009; 647
2019; 150
2019; 392
2021; 84
2016; 48
2021; 49
2021; 48
2021; 45
2020; 41
2020; 261
2015; 363
2015; 362
2019; 39
2020; 39
2019; 38
2020; 387
2008; 123
2016; 15
2016; 11
2016; 6
2016; 7
2021; 54
2019; 40
2020; 394
2019; 46
2017; 56
2010; 295
2020; 25
2020; 24
2021; 892
2020; 21
2021; 62
2016; 24
2016; 22
2013; 27
2019; 52
2020; 242
2020; 121
2020; 129
2020; 58
2020; 485
2021; 122
2008; 75
2020; 8
2017; 30
2017; 37
2020; 53
2021; 476
2020; 132
2018; 415
2021; 237
2020; 9
2020; 44
2020; 256
2010; 1805
2016; 114
2020; 43
2007; 21
2001; 14
2007; 26
2021; 9
2021; 8
2021; 6
2015; 6
2014; 92
2015; 5
2021; 86
2021; 908
2017; 25
2019; 76
2013; 42
2007; 120
2010; 80
2020; 1874
2017; 109
2017; 17
2017; 16
2007; 110
2017; 11
2020; 71
2018; 432
2018; 431
2017; 12
2018
2018; 52
2020; 111
2017; 18
2020; 235
2018; 53
2019; 2019
2021; 167
2021; 288
2012; 246
2018; 42
2013; 6
2018; 7
2015; 89
2018; 6
2018; 9
2018; 8
2018; 39
2018; 4
2021; 278
2021; 157
2021; 277
2020b; 72
2021; 270
2021; 272
2006; 281
2021; 275
2018; 1865
2018; 37
2021; 2021
2019; 8
2019; 9
2021; 268
2018; 503
2015; 54
2021; 140
2021; 260
2019; 108
2021; 141
2021; 144
2018; 23
2018; 22
2018; 24
2018; 18
2021; 136
2019; 457
2021; 130
2021; 133
2018; 11
2018; 10
2018; 15
2019; 1871
1976; 21
2021; 25
2021; 24
2017; 6
2017; 8
2015; 36
2021; 26
2021; 21
2021; 20
2021; 23
2021; 22
2015; 589
2021; 29
2015; 464
2015; 32
2019; 124
2020; 524
2020; 881
2020; 526
2020; 889
2019; 120
2021; 36
2021; 35
2021; 32
2021; 34
2018; 498
2020; 530
2021; 41
2021; 40
2021; 191
2021; 508
2018; 143
2021; 509
2015; 16
2021; 183
2019; 147
2014; 111
2021; S1044–1579X
2021; 180
2014; 354
2021; 14
2021; 13
2015; 26
2021; 15
2021; 10
2017; 90
2021; 12
2021; 11
2021; 17
2021; 171
e_1_2_13_120_1
e_1_2_13_143_1
e_1_2_13_166_1
e_1_2_13_189_1
e_1_2_13_20_1
e_1_2_13_66_1
e_1_2_13_43_1
e_1_2_13_181_1
e_1_2_13_226_1
e_1_2_13_249_1
e_1_2_13_8_1
e_1_2_13_81_1
e_1_2_13_252_1
e_1_2_13_275_1
e_1_2_13_92_1
e_1_2_13_117_1
e_1_2_13_214_1
e_1_2_13_290_1
e_1_2_13_17_1
e_1_2_13_154_1
e_1_2_13_131_1
e_1_2_13_32_1
e_1_2_13_55_1
e_1_2_13_78_1
e_1_2_13_177_1
e_1_2_13_215_1
Chen Q. (e_1_2_13_48_1) 2018; 11
e_1_2_13_192_1
e_1_2_13_238_1
e_1_2_13_70_1
e_1_2_13_241_1
e_1_2_13_287_1
e_1_2_13_264_1
e_1_2_13_203_1
e_1_2_13_105_1
e_1_2_13_88_1
e_1_2_13_128_1
e_1_2_13_29_1
e_1_2_13_165_1
e_1_2_13_142_1
e_1_2_13_21_1
e_1_2_13_44_1
e_1_2_13_67_1
e_1_2_13_104_1
e_1_2_13_188_1
e_1_2_13_9_1
e_1_2_13_248_1
e_1_2_13_180_1
e_1_2_13_251_1
e_1_2_13_91_1
e_1_2_13_274_1
e_1_2_13_236_1
e_1_2_13_116_1
e_1_2_13_213_1
e_1_2_13_99_1
e_1_2_13_139_1
e_1_2_13_18_1
e_1_2_13_130_1
e_1_2_13_153_1
e_1_2_13_79_1
e_1_2_13_10_1
e_1_2_13_56_1
e_1_2_13_115_1
e_1_2_13_176_1
e_1_2_13_199_1
e_1_2_13_33_1
e_1_2_13_237_1
e_1_2_13_71_1
e_1_2_13_191_1
e_1_2_13_240_1
e_1_2_13_263_1
e_1_2_13_286_1
Rovensky Yu A. (e_1_2_13_210_1) 2001; 14
e_1_2_13_225_1
e_1_2_13_202_1
e_1_2_13_127_1
e_1_2_13_122_1
e_1_2_13_68_1
e_1_2_13_45_1
e_1_2_13_145_1
e_1_2_13_168_1
e_1_2_13_205_1
e_1_2_13_22_1
e_1_2_13_60_1
e_1_2_13_83_1
e_1_2_13_183_1
e_1_2_13_228_1
e_1_2_13_6_1
e_1_2_13_160_1
e_1_2_13_90_1
e_1_2_13_231_1
e_1_2_13_254_1
e_1_2_13_277_1
e_1_2_13_98_1
e_1_2_13_119_1
Li H. (e_1_2_13_125_1) 2019; 12
e_1_2_13_19_1
e_1_2_13_292_1
e_1_2_13_133_1
e_1_2_13_179_1
e_1_2_13_57_1
e_1_2_13_110_1
e_1_2_13_217_1
e_1_2_13_11_1
e_1_2_13_34_1
e_1_2_13_156_1
e_1_2_13_171_1
e_1_2_13_72_1
e_1_2_13_194_1
e_1_2_13_220_1
e_1_2_13_243_1
e_1_2_13_266_1
e_1_2_13_289_1
e_1_2_13_107_1
Gu K. (e_1_2_13_82_1) 2015; 5
e_1_2_13_281_1
e_1_2_13_121_1
e_1_2_13_144_1
e_1_2_13_46_1
e_1_2_13_69_1
e_1_2_13_23_1
e_1_2_13_167_1
e_1_2_13_204_1
e_1_2_13_84_1
e_1_2_13_182_1
e_1_2_13_227_1
e_1_2_13_7_1
e_1_2_13_61_1
e_1_2_13_230_1
e_1_2_13_276_1
e_1_2_13_253_1
e_1_2_13_97_1
e_1_2_13_118_1
e_1_2_13_291_1
e_1_2_13_132_1
e_1_2_13_155_1
e_1_2_13_178_1
e_1_2_13_35_1
e_1_2_13_58_1
e_1_2_13_216_1
e_1_2_13_12_1
e_1_2_13_170_1
e_1_2_13_193_1
e_1_2_13_73_1
e_1_2_13_239_1
e_1_2_13_50_1
e_1_2_13_265_1
e_1_2_13_242_1
e_1_2_13_288_1
e_1_2_13_129_1
e_1_2_13_280_1
e_1_2_13_24_1
e_1_2_13_47_1
e_1_2_13_185_1
e_1_2_13_207_1
e_1_2_13_101_1
e_1_2_13_147_1
e_1_2_13_124_1
e_1_2_13_85_1
e_1_2_13_62_1
e_1_2_13_162_1
e_1_2_13_233_1
e_1_2_13_256_1
e_1_2_13_279_1
e_1_2_13_96_1
e_1_2_13_271_1
e_1_2_13_13_1
e_1_2_13_36_1
e_1_2_13_59_1
e_1_2_13_219_1
e_1_2_13_112_1
e_1_2_13_158_1
e_1_2_13_196_1
e_1_2_13_135_1
e_1_2_13_51_1
e_1_2_13_74_1
e_1_2_13_173_1
e_1_2_13_150_1
e_1_2_13_222_1
e_1_2_13_245_1
e_1_2_13_268_1
e_1_2_13_4_1
e_1_2_13_109_1
e_1_2_13_283_1
e_1_2_13_260_1
e_1_2_13_25_1
e_1_2_13_100_1
e_1_2_13_169_1
e_1_2_13_206_1
e_1_2_13_123_1
e_1_2_13_86_1
e_1_2_13_146_1
e_1_2_13_40_1
e_1_2_13_63_1
Zhang Y. (e_1_2_13_285_1) 2021; 11
e_1_2_13_184_1
e_1_2_13_229_1
e_1_2_13_161_1
e_1_2_13_232_1
e_1_2_13_255_1
e_1_2_13_95_1
e_1_2_13_278_1
e_1_2_13_270_1
e_1_2_13_14_1
e_1_2_13_111_1
e_1_2_13_37_1
e_1_2_13_218_1
e_1_2_13_134_1
e_1_2_13_157_1
e_1_2_13_75_1
e_1_2_13_52_1
e_1_2_13_172_1
e_1_2_13_195_1
e_1_2_13_221_1
e_1_2_13_5_1
e_1_2_13_244_1
e_1_2_13_267_1
e_1_2_13_108_1
e_1_2_13_282_1
e_1_2_13_49_1
e_1_2_13_141_1
e_1_2_13_164_1
e_1_2_13_209_1
e_1_2_13_26_1
e_1_2_13_126_1
e_1_2_13_87_1
e_1_2_13_187_1
e_1_2_13_64_1
e_1_2_13_103_1
e_1_2_13_41_1
e_1_2_13_273_1
e_1_2_13_94_1
e_1_2_13_235_1
e_1_2_13_258_1
e_1_2_13_138_1
e_1_2_13_212_1
e_1_2_13_250_1
e_1_2_13_15_1
e_1_2_13_38_1
e_1_2_13_152_1
e_1_2_13_137_1
e_1_2_13_175_1
e_1_2_13_53_1
e_1_2_13_76_1
e_1_2_13_114_1
e_1_2_13_198_1
e_1_2_13_259_1
e_1_2_13_30_1
e_1_2_13_190_1
e_1_2_13_262_1
e_1_2_13_224_1
e_1_2_13_247_1
e_1_2_13_2_1
e_1_2_13_201_1
e_1_2_13_149_1
e_1_2_13_27_1
e_1_2_13_163_1
e_1_2_13_208_1
e_1_2_13_102_1
e_1_2_13_148_1
e_1_2_13_186_1
e_1_2_13_42_1
e_1_2_13_65_1
Kim D. A. (e_1_2_13_106_1) 2019; 9
e_1_2_13_80_1
e_1_2_13_140_1
e_1_2_13_93_1
e_1_2_13_234_1
e_1_2_13_257_1
e_1_2_13_211_1
e_1_2_13_39_1
e_1_2_13_272_1
e_1_2_13_16_1
e_1_2_13_113_1
e_1_2_13_136_1
e_1_2_13_159_1
e_1_2_13_174_1
e_1_2_13_197_1
e_1_2_13_31_1
e_1_2_13_77_1
e_1_2_13_54_1
e_1_2_13_151_1
e_1_2_13_284_1
e_1_2_13_223_1
e_1_2_13_269_1
e_1_2_13_3_1
e_1_2_13_246_1
e_1_2_13_89_1
e_1_2_13_200_1
e_1_2_13_28_1
e_1_2_13_261_1
References_xml – volume: 508
  start-page: 104
  year: 2021
  end-page: 114
  article-title: Long non‐coding RNAs in the doxorubicin resistance of cancer cells
  publication-title: Cancer Letters
– volume: 11
  year: 2021
  article-title: FER regulated by miR‐206 promotes hepatocellular carcinoma progression via NF‐κB signaling
  publication-title: Frontiers in Oncology
– volume: 45
  start-page: 717
  issue: 2
  year: 2021
  end-page: 727
  article-title: Chlorogenic acid induces apoptosis, inhibits metastasis and improves antitumor immunity in breast cancer via the NF‑κB signaling pathway
  publication-title: Oncology Reports
– volume: 122
  start-page: 1302
  issue: 10
  year: 2021
  end-page: 1312
  article-title: A novel lncRNA LOLA1 may predict malignant progression and promote migration, invasion, and EMT of oral leukoplakia via the AKT/GSK‐3β pathway
  publication-title: Journal of Cellular Biochemistry
– volume: 53
  issue: 3
  year: 2020
  article-title: IL‐6 promotes metastasis of non‐small‐cell lung cancer by up‐regulating TIM‐4 via NF‐κB
  publication-title: Cell Proliferation
– volume: 141
  year: 2021
  article-title: New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities
  publication-title: Biomedicine & Pharmacotherapy
– volume: 447
  year: 2021
  article-title: AIE‐featured tetraphenylethylene nanoarchitectures in biomedical application: Bioimaging, drug delivery and disease treatment
  publication-title: Coordination Chemistry Reviews
– volume: 278
  year: 2021
  article-title: Therapeutic potential of AMPK signaling targeting in lung cancer: Advances, challenges and future prospects
  publication-title: Life Sciences
– volume: 21
  start-page: 66
  issue: 1
  year: 2021
  article-title: Anti‐tumor activity of resveratrol against gastric cancer: A review of recent advances with an emphasis on molecular pathways
  publication-title: Cancer Cell International
– volume: 35
  start-page: 155
  issue: 1
  year: 2021
  end-page: 179
  article-title: Recent advances and future directions in anti‐tumor activity of cryptotanshinone: A mechanistic review
  publication-title: Phytotherapy Research
– volume: 10
  issue: 12
  year: 2021
  article-title: Pre‐clinical and clinical applications of small interfering RNAs (siRNA) and co‐delivery systems for pancreatic cancer therapy
  publication-title: Cells
– volume: 48
  start-page: 2365
  issue: 3
  year: 2021
  end-page: 2375
  article-title: TGF‐β promote epithelial‐mesenchymal transition via NF‐κB/NOX4/ROS signal pathway in lung cancer cells
  publication-title: Molecular Biology Reports
– volume: 10
  issue: 12
  year: 2018
  article-title: Dysregulation of Nrf2 in hepatocellular carcinoma: Role in cancer progression and chemoresistance
  publication-title: Cancers
– volume: 11
  start-page: 3812
  issue: 7
  year: 2018
  end-page: 3824
  article-title: microRNA‐340 influences cell proliferation, apoptosis and invasion by targeting NF‐κB1 in gastric cancer
  publication-title: International Journal of Clinical and Experimental Pathology
– volume: 8
  year: 2020
  article-title: Ethyl pyruvate inhibits glioblastoma cells migration and invasion through modulation of NF‐κB and ERK‐mediated EMT
  publication-title: PeerJ
– volume: 26
  start-page: 7324
  issue: 52
  year: 2007
  end-page: 7332
  article-title: Epidermal growth factor (EGF) activates nuclear factor‐kappaB through IkappaBalpha kinase‐independent but EGF receptor‐kinase dependent tyrosine 42 phosphorylation of IkappaBalpha
  publication-title: Oncogene
– volume: 24
  start-page: 14525
  issue: 24
  year: 2020
  end-page: 14538
  article-title: Thidiazuron decreases epithelial‐mesenchymal transition activity through the NF‐κB and PI3K/AKT signalling pathways in breast cancer
  publication-title: Journal of Cellular and Molecular Medicine
– volume: 21
  start-page: 2642
  issue: 11
  year: 2007
  end-page: 2654
  article-title: Beyond IkappaBs: Alternative regulation of NF‐kappa B activity
  publication-title: The FASEB Journal
– volume: 464
  start-page: 705
  issue: 3
  year: 2015
  end-page: 710
  article-title: Sinomenine inhibits breast cancer cell invasion and migration by suppressing NF‐κB activation mediated by IL‐4/miR‐324‐5p/CUEDC2 axis
  publication-title: Biochemical and Biophysical Research Communications
– volume: 8
  start-page: 2808
  issue: 1
  year: 2018
  article-title: jellyfish venom exerts an anti‐metastatic effect by inhibiting Smad‐ and NF‐κB‐mediated epithelial‐mesenchymal transition in HepG2 cells
  publication-title: Scientific Reports
– volume: 256
  year: 2020
  article-title: MicroRNAs in cancer therapy: Their involvement in oxaliplatin sensitivity/resistance of cancer cells with a focus on colorectal cancer
  publication-title: Life Sciences
– volume: 180
  start-page: 608
  year: 2021
  end-page: 624
  article-title: The role of SOX family transcription factors in gastric cancer
  publication-title: International Journal of Biological Macromolecules
– volume: 363
  start-page: 28
  issue: 1
  year: 2015
  end-page: 36
  article-title: Isorhamnetin augments the anti‐tumor effect of capecitabine through the negative regulation of NF‐κB signaling cascade in gastric cancer
  publication-title: Cancer Letters
– volume: 39
  start-page: 59
  issue: 1
  year: 2020
  article-title: Cullin‐7 (CUL7) is overexpressed in glioma cells and promotes tumorigenesis via NF‐κB activation
  publication-title: Journal of Experimental & Clinical Cancer Research
– volume: 24
  issue: 8
  year: 2019
  article-title: Brassinin represses invasive potential of lung carcinoma cells through deactivation of PI3K/Akt/mTOR signaling cascade
  publication-title: Molecules
– volume: 19
  start-page: 519
  issue: 1
  year: 2020
  end-page: 526
  article-title: Oxymatrine reverses 5‐fluorouracil resistance by inhibition of colon cancer cell epithelial‐mesenchymal transition and NF‐κB signaling in vitro
  publication-title: Oncology Letters
– volume: 36
  start-page: 2747
  issue: 4
  year: 2015
  end-page: 2761
  article-title: (‐)‐Epigallocatechin‐3‐gallate inhibits nasopharyngeal cancer stem cell self‐renewal and migration and reverses the epithelial‐mesenchymal transition via NF‐κB p65 inactivation
  publication-title: Tumor Biology
– volume: 13
  issue: 1
  year: 2021
  article-title: Flavonoids targeting HIF‐1: Implications on cancer metabolism
  publication-title: Cancers
– volume: 27
  start-page: 2368
  issue: 12
  year: 2019
  end-page: 2375
  article-title: Caged‐xanthone from ssp. inhibits malignant cancer phenotypes in multidrug‐resistant human A549 lung cancer cells through down‐regulation of NF‐κB
  publication-title: Bioorganic & Medicinal Chemistry
– volume: 15
  start-page: 237
  issue: 2
  year: 2021
  end-page: 250
  article-title: Long non‐coding RNA DIO3OS/let‐7d/NF‐κB2 axis regulates cells proliferation and metastasis of thyroid cancer cells
  publication-title: Journal of Cell Communication and Signaling
– volume: 13
  issue: 20
  year: 2021
  article-title: KLF4 induces mesenchymal‐epithelial transition (MET) by suppressing multiple EMT‐inducing transcription factors
  publication-title: Cancers
– volume: 23
  start-page: 6907
  issue: 10
  year: 2019
  end-page: 6918
  article-title: S100A11 functions as novel oncogene in glioblastoma via S100A11/ANXA2/NF‐κB positive feedback loop
  publication-title: Journal of Cellular and Molecular Medicine
– year: 2018
  article-title: Catalpol inhibits TGF‐β1‐induced epithelial‐mesenchymal transition in human non‐small‐cell lung cancer cells through the inactivation of Smad2/3 and NF‐κB signaling pathways
– volume: 272
  year: 2021
  article-title: Hyaluronic acid‐based nanoplatforms for Doxorubicin: A review of stimuli‐responsive carriers, co‐delivery and resistance suppression
  publication-title: Carbohydrate Polymers
– volume: 23
  start-page: 177
  issue: 3
  year: 2018
  end-page: 187
  article-title: Pax‐5 inhibits NF‐κB activity in breast cancer cells through IKKε and miRNA‐155 effectors
  publication-title: Journal of Mammary Gland Biology and Neoplasia
– volume: 21
  issue: 14
  year: 2020
  article-title: Small molecule NF‐κB pathway inhibitors in clinic
  publication-title: International Journal of Molecular Sciences
– volume: 84
  year: 2021
  article-title: Sulforaphane‐cisplatin combination inhibits the stemness and metastatic potential of TNBCs via down regulation of sirtuins‐mediated EMT signaling axis
  publication-title: Phytomedicine
– volume: 270
  year: 2021
  article-title: Dual relationship between long non‐coding RNAs and STAT3 signaling in different cancers: New insight to proliferation and metastasis
  publication-title: Life Sciences
– volume: 415
  start-page: 73
  year: 2018
  end-page: 85
  article-title: Ginsenoside Rg3 sensitizes hypoxic lung cancer cells to cisplatin via blocking of NF‐κB mediated epithelial‐mesenchymal transition and stemness
  publication-title: Cancer Letters
– volume: 143
  start-page: 2213
  issue: 9
  year: 2018
  end-page: 2224
  article-title: LncRNA NKILA suppresses TGF‐β‐induced epithelial‐mesenchymal transition by blocking NF‐κB signaling in breast cancer
  publication-title: International Journal of Cancer
– volume: 37
  start-page: 793
  issue: 2
  year: 2017
  end-page: 802
  article-title: 2‐Methoxyestradiol inhibits the proliferation and migration and reduces the radioresistance of nasopharyngeal carcinoma CNE‐2 stem cells via NF‐κB/HIF‐1 signaling pathway inactivation and EMT reversal
  publication-title: Oncology Reports
– volume: 889
  year: 2020
  article-title: Betulinic acid inhibits cell proliferation and migration in gastric cancer by targeting the NF‐κB/VASP pathway
  publication-title: European Journal of Pharmacology
– volume: 9
  issue: 9
  year: 2021
  article-title: NF‐κB‐dependent and ‐independent (moonlighting) IκBα functions in differentiation and cancer
  publication-title: Biomedicines
– volume: 18
  issue: 9
  year: 2017
  article-title: miR‐145‐5p suppresses tumor cell migration, invasion and epithelial to mesenchymal transition by regulating the Sp1/NF‐κB signaling pathway in esophageal squamous cell carcinoma
  publication-title: International Journal of Molecular Sciences
– volume: 387
  issue: 2
  year: 2020
  article-title: miR‐200b/c‐RAP1B axis represses tumorigenesis and malignant progression of papillary thyroid carcinoma through inhibiting the NF‐κB/Twist1 pathway
  publication-title: Experimental Cell Research
– volume: 76
  start-page: 1947
  issue: 10
  year: 2019
  end-page: 1966
  article-title: Long non‐coding RNAs are emerging targets of phytochemicals for cancer and other chronic diseases
  publication-title: Cellular and Molecular Life Sciences
– volume: 12
  year: 2021
  article-title: Total flavonoids of litchi seed attenuate prostate cancer progression via inhibiting AKT/mTOR and NF‐κB signaling pathways
  publication-title: Frontiers in Pharmacology
– volume: 54
  start-page: 971
  issue: 10
  year: 2015
  end-page: 985
  article-title: Abrogation of STAT3 signaling cascade by zerumbone inhibits proliferation and induces apoptosis in renal cell carcinoma xenograft mouse model
  publication-title: Molecular Carcinogenesis
– volume: 24
  start-page: 66
  issue: 1
  year: 2018
  end-page: 84
  article-title: Noncoding RNAs: Master regulators of inflammatory signaling
  publication-title: Trends in Molecular Medicine
– volume: 41
  start-page: 1291
  issue: 3
  year: 2020
  end-page: 1336
  article-title: The pleiotropic role of transcription factor STAT3 in oncogenesis and its targeting through natural products for cancer prevention and therapy
  publication-title: Medicinal Research Reviews
– volume: 10
  issue: 5
  year: 2018
  article-title: Pro‐apoptotic and anti‐cancer properties of diosgenin: A comprehensive and critical review
  publication-title: Nutrients
– volume: 25
  start-page: 809
  issue: 5
  year: 2017
  end-page: 817
  article-title: Kallistatin suppresses cell proliferation and invasion and promotes apoptosis in cervical cancer through blocking NF‐κB signaling
  publication-title: Oncology Research
– volume: 503
  start-page: 2152
  issue: 3
  year: 2018
  end-page: 2159
  article-title: Effects of saponins of patrinia villosa against invasion and metastasis in colorectal cancer cell through NF‐κB signaling pathway and EMT
  publication-title: Biochemical and Biophysical Research Communications
– volume: 21
  start-page: 749
  issue: 9
  year: 2021
  end-page: 767
  article-title: Role of ZEB family members in proliferation, metastasis, and chemoresistance of prostate cancer cells: Revealing signaling networks
  publication-title: Current Cancer Drug Targets
– volume: 281
  start-page: 19798
  issue: 29
  year: 2006
  end-page: 19808
  article-title: Genetic deletion of NAD(P)H:quinone oxidoreductase 1 abrogates activation of nuclear factor‐kappaB, IkappaBalpha kinase, c‐Jun N‐terminal kinase, Akt, p38, and p44/42 mitogen‐activated protein kinases and potentiates apoptosis
  publication-title: Journal of Biological Chemistry
– volume: 10
  issue: 8
  year: 2020
  article-title: CD13 promotes hepatocellular carcinogenesis and sorafenib resistance by activating HDAC5‐LSD1‐NF‐κB oncogenic signaling
  publication-title: Clinical and Translational Medicine
– volume: 37
  start-page: 2095
  issue: 4
  year: 2017
  end-page: 2100
  article-title: CXCL8 induces epithelial‐mesenchymal transition in colon cancer cells via the PI3K/Akt/NF‐κB signaling pathway
  publication-title: Oncology Reports
– volume: 40‐41
  start-page: 100
  year: 2016
  end-page: 115
  article-title: Potential of neem ( L.) for prevention and treatment of oncologic diseases
  publication-title: Seminars in Cancer Biology
– volume: 20
  start-page: 918
  issue: 8
  year: 2020
  end-page: 931
  article-title: Anti‐tumor effects of osthole on different malignant tissues: A review of molecular mechanisms
  publication-title: Anti‐Cancer Agents in Medicinal Chemistry
– volume: 9
  issue: 9
  year: 2021
  article-title: Stationed or relocating: The seesawing EMT/MET determinants from embryonic development to cancer metastasis
  publication-title: Biomedicines
– volume: 9
  start-page: 386
  issue: 3
  year: 2018
  article-title: Rap1 deficiency‐provoked paracrine dysfunction impairs immunosuppressive potency of mesenchymal stem cells in allograft rejection of heart transplantation
  publication-title: Cell Death and Disease
– volume: 432
  start-page: 38
  year: 2018
  end-page: 46
  article-title: IGFBP2 promotes salivary adenoid cystic carcinoma metastasis by activating the NF‐κB/ZEB1 signaling pathway
  publication-title: Cancer Letters
– volume: 42
  start-page: 1801
  issue: 5
  year: 2013
  end-page: 1806
  article-title: Low‐dose radiation‐induced epithelial‐mesenchymal transition through NF‐κB in cervical cancer cells
  publication-title: International Journal of Oncology
– volume: 11
  issue: 1
  year: 2020
  article-title: Phosphorylation of the regulators, a complex facet of NF‐κB signaling in cancer
  publication-title: Biomolecules
– volume: 25
  issue: 3
  year: 2020
  article-title: Curcumin delivery mediated by bio‐based nanoparticles: A review
  publication-title: Molecules
– volume: 6
  start-page: 42717
  issue: 40
  year: 2015
  end-page: 42732
  article-title: NF‐κB drives acquired resistance to a novel mutant‐selective EGFR inhibitor
  publication-title: Oncotarget
– volume: 14
  start-page: 5633
  year: 2020
  end-page: 5644
  article-title: Magnesium isoglycyrrhizinate induces an inhibitory effect on progression and epithelial‐mesenchymal transition of laryngeal cancer via the NF‐κB/twist signaling
  publication-title: Drug Design, Development and Therapy
– volume: 20
  issue: 3
  year: 2019
  article-title: Hypoxia induced ER stress response as an adaptive mechanism in cancer
  publication-title: International Journal of Molecular Sciences
– volume: 11
  start-page: 1055
  issue: 12
  year: 2020
  article-title: NF‐κB‐mediated lncRNA AC007271.3 promotes carcinogenesis of oral squamous cell carcinoma by regulating miR‐125b‐2‐3p/Slug
  publication-title: Cell Death and Disease
– volume: 25
  start-page: 10961
  issue: 23
  year: 2021
  end-page: 10972
  article-title: Rad50 promotes ovarian cancer progression through NF‐κB activation
  publication-title: Journal of Cellular and Molecular Medicine
– volume: 167
  year: 2021
  article-title: Nrf2 signaling pathway in cisplatin chemotherapy: Potential involvement in organ protection and chemoresistance
  publication-title: Pharmacological Research
– volume: 530
  start-page: 122
  issue: 1
  year: 2020
  end-page: 129
  article-title: Activation of NF‐κB by TOPK upregulates Snail/Slug expression in TGF‐β1 signaling to induce epithelial‐mesenchymal transition and invasion of breast cancer cells
  publication-title: Biochemical and Biophysical Research Communications
– volume: 42
  start-page: 443
  year: 2013
  end-page: 468
  article-title: Molecular basis of NF‐κB signaling
  publication-title: Annual Review of Biophysics
– volume: 8
  start-page: 4633
  issue: 17
  year: 2018
  end-page: 4648
  article-title: Aphthous ulcer drug inhibits prostate tumor metastasis by targeting IKKɛ/TBK1/NF‐κB signaling
  publication-title: Theranostics
– volume: 42
  start-page: 288
  issue: 3
  year: 2018
  end-page: 297
  article-title: Korean Red Ginseng extract reduces hypoxia‐induced epithelial‐mesenchymal transition by repressing NF‐κB and ERK1/2 pathways in colon cancer
  publication-title: Journal of Ginseng Research
– volume: 8
  start-page: 104855
  issue: 62
  year: 2017
  end-page: 104866
  article-title: Doxycycline inhibits breast cancer EMT and metastasis through PAR‐1/NF‐κB/miR‐17/E‐cadherin pathway
  publication-title: Oncotarget
– volume: 123
  start-page: 1733
  issue: 8
  year: 2008
  end-page: 1740
  article-title: Simvastatin, 3‐hydroxy‐3‐methylglutaryl coenzyme A reductase inhibitor, suppresses osteoclastogenesis induced by receptor activator of nuclear factor‐kappaB ligand through modulation of NF‐kappaB pathway
  publication-title: International Journal of Cancer
– volume: 129
  year: 2020
  article-title: Long non‐coding RNA NKILA inhibited angiogenesis of breast cancer through NF‐κB/IL‐6 signaling pathway
  publication-title: Microvascular Research
– volume: 498
  start-page: 862
  issue: 4
  year: 2018
  end-page: 868
  article-title: CXCL5 promotes mitomycin C resistance in non‐muscle invasive bladder cancer by activating EMT and NF‐κB pathway
  publication-title: Biochemical and Biophysical Research Communications
– volume: 26
  start-page: 907
  issue: 3
  year: 2019
  end-page: 917
  article-title: Roles of Pin1 as a key molecule for EMT induction by activation of STAT3 and NF‐κB in human gallbladder cancer
  publication-title: Annals of Surgical Oncology
– volume: 6
  issue: 1
  year: 2017
  article-title: Current insights to regulation and role of telomerase in human diseases
  publication-title: Antioxidants (Basel)
– volume: 17
  start-page: 813
  issue: 1
  year: 2017
  article-title: Genistein induces apoptosis of colon cancer cells by reversal of epithelial‐to‐mesenchymal via a Notch1/NF‐κB/slug/E‐cadherin pathway
  publication-title: BMC Cancer
– volume: 8
  start-page: 1415
  year: 2021
  end-page: 1444
  article-title: Wnt/β‐catenin signaling as a driver of hepatocellular carcinoma progression: An emphasis on molecular pathways
  publication-title: Journal of Hepatocellular Carcinoma
– volume: 457
  start-page: 83
  issue: 1–2
  year: 2019
  end-page: 91
  article-title: Activation of EMT in colorectal cancer by MTDH/NF‐κB p65 pathway
  publication-title: Molecular and Cellular Biochemistry
– volume: 108
  start-page: 17
  year: 2019
  end-page: 20
  article-title: The expanding roles of long non‐coding RNAs in the regulation of cancer stem cells
  publication-title: International Journal of Biochemistry & Cell Biology
– volume: 275
  year: 2021
  article-title: Small interfering RNA (siRNA) to target genes and molecular pathways in glioblastoma therapy: Current status with an emphasis on delivery systems
  publication-title: Life Sciences
– volume: 242
  year: 2020
  article-title: PHD2 exerts anti‐cancer and anti‐inflammatory effects in colon cancer xenografts mice via attenuating NF‐κB activity
  publication-title: Life Sciences
– volume: 10
  issue: 7
  year: 2020
  article-title: MicroRNAs and their influence on the ZEB Family: Mechanistic aspects and therapeutic applications in cancer therapy
  publication-title: Biomolecules
– volume: 130
  start-page: 20
  year: 2021
  end-page: 30
  article-title: Curcumin and inflammatory bowel diseases: From in vitro studies to clinical trials
  publication-title: Molecular Immunology
– volume: 68
  start-page: 702
  issue: 4
  year: 2021
  end-page: 710
  article-title: SPOCK1 promotes the proliferation and migration of colon cancer cells by regulating the NF‐κB pathway and inducing EMT
  publication-title: Neoplasma
– volume: 13
  start-page: 2575
  issue: 2
  year: 2020
  end-page: 2592
  article-title: β‐Elemene enhances radiosensitivity in non‐small‐cell lung cancer by inhibiting epithelial‐mesenchymal transition and cancer stem cell traits via Prx‐1/NF‐κB/iNOS signaling pathway
  publication-title: Aging
– volume: 38
  start-page: 5873
  issue: 30
  year: 2019
  end-page: 5889
  article-title: Cancer cell‐derived long pentraxin 3 (PTX3) promotes melanoma migration through a toll‐like receptor 4 (TLR4)/NF‐κB signaling pathway
  publication-title: Oncogene
– volume: 37
  start-page: 283
  issue: 1
  year: 2018
  article-title: EBV‐miR‐BART8‐3p induces epithelial‐mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma cells through activating NF‐κB and Erk1/2 pathways
  publication-title: Journal of Experimental & Clinical Cancer Research
– volume: 89
  start-page: 711
  issue: 5
  year: 2015
  end-page: 731
  article-title: NF‐κB in cancer therapy
  publication-title: Archives of Toxicology
– volume: 15
  start-page: 77
  issue: 1
  year: 2016
  article-title: Lipocalin2 suppresses metastasis of colorectal cancer by attenuating NF‐κB‐dependent activation of snail and epithelial mesenchymal transition
  publication-title: Molecular Cancer
– volume: 21
  start-page: 372
  issue: 3
  year: 2021
  end-page: 382
  article-title: Eupatilin inhibits the proliferation and migration of prostate cancer cells through modulation of PTEN and NF‐κB signaling
  publication-title: Anti‐Cancer Agents in Medicinal Chemistry
– volume: 16
  start-page: 898
  issue: 6
  year: 2015
  end-page: 911
  article-title: Autocrine IL‐8 promotes F‐actin polymerization and mediate mesenchymal transition via ELMO1‐NF‐κB‐Snail signaling in glioma
  publication-title: Cancer Biology & Therapy
– volume: 10
  issue: 8
  year: 2020
  article-title: Role of microRNA/epithelial‐to‐mesenchymal transition axis in the metastasis of bladder cancer
  publication-title: Biomolecules
– volume: 237
  start-page: 450
  year: 2021
  end-page: 465
  article-title: Long noncoding RNAs: A novel insight in the leukemogenesis and drug resistance in acute myeloid leukemia
  publication-title: Journal of Cellular Physiology
– volume: 8
  start-page: 92240
  issue: 54
  year: 2017
  end-page: 92253
  article-title: Acquisition of EGFR TKI resistance and EMT phenotype is linked with activation of IGF1R/NF‐κB pathway in EGFR‐mutant NSCLC
  publication-title: Oncotarget
– volume: 6
  issue: 3
  year: 2018
  article-title: Evidence for the involvement of the master transcription factor NF‐κB in cancer initiation and progression
  publication-title: Biomedicines
– volume: 14
  start-page: 1146
  issue: 6
  year: 2021
  end-page: 1155
  article-title: Curcumin efficacy in a serum/glucose deprivation‐induced neuronal PC12 injury model
  publication-title: Current Molecular Pharmacology
– volume: 120
  start-page: 2545
  issue: 12
  year: 2007
  end-page: 2556
  article-title: Expression of NF‐kappaB parallels COX‐2 expression in oral precancer and cancer: Association with smokeless tobacco
  publication-title: International Journal of Cancer
– volume: 43
  start-page: 1558
  issue: 5
  year: 2020
  end-page: 1568
  article-title: AREG mediates the epithelial‑mesenchymal transition in pancreatic cancer cells via the EGFR/ERK/NF‑κB signalling pathway
  publication-title: Oncology Reports
– volume: 25
  issue: 10
  year: 2020
  article-title: Pretreatment of anthocyanin from the fruit of vitis coignetiae pulliat acts as a potent inhibitor of TNF‐α effect by inhibiting NF‐κB‐regulated genes in human breast cancer cells
  publication-title: Molecules
– volume: 1865
  start-page: 545
  issue: 4
  year: 2018
  end-page: 550
  article-title: induces direct activation of the lymphotoxin beta receptor and non‐canonical nuclear factor‐kappa B signaling
  publication-title: Biochimica et Biophysica Acta–Molecular Cell Research
– volume: 392
  start-page: 1359
  issue: 11
  year: 2019
  end-page: 1369
  article-title: MiR‐940 inhibits migration and invasion of tongue squamous cell carcinoma via regulatingCXCR2/NF‐κB system‐mediated epithelial‐mesenchymal transition
  publication-title: Naunyn‐Schmiedeberg's Archives of Pharmacology
– volume: 9
  year: 2018
  article-title: Celastrol attenuates the invasion and migration and augments the anticancer effects of bortezomib in a xenograft mouse model of multiple myeloma
  publication-title: Frontiers in Pharmacology
– volume: 69
  start-page: 5
  year: 2021
  end-page: 23
  article-title: Natural product‐based nanoformulations for cancer therapy: Opportunities and challenges
  publication-title: Seminars in Cancer Biology
– volume: 235
  start-page: 4135
  issue: 5
  year: 2020
  end-page: 4145
  article-title: Resveratrol targeting the Wnt signaling pathway: A focus on therapeutic activities
  publication-title: Journal of Cellular Physiology
– volume: 9
  year: 2018
  article-title: Thymoquinone inhibits bone metastasis of breast cancer cells through abrogation of the CXCR4 signaling axis
  publication-title: Frontiers in Pharmacology
– volume: 10
  start-page: 5349
  issue: 1
  year: 2019
  article-title: Rap1 regulates hematopoietic stem cell survival and affects oncogenesis and response to chemotherapy
  publication-title: Nature Communications
– volume: 136
  year: 2021
  article-title: Curcumin and cardiovascular diseases: Focus on cellular targets and cascades
  publication-title: Biomedicine & Pharmacotherapy
– volume: 1874
  issue: 2
  year: 2020
  article-title: The implication of long non‐coding RNAs in the diagnosis, pathogenesis and drug resistance of pancreatic ductal adenocarcinoma and their possible therapeutic potential
  publication-title: Biochimica et Biophysica Acta–Reviews on Cancer
– volume: 23
  start-page: 1847
  issue: 9
  year: 2021
  end-page: 1856
  article-title: Medical ozone induces proliferation and migration inhibition through ROS accumulation and PI3K/AKT/NF‐κB suppression in human liver cancer cells in vitro
  publication-title: Clinical and Translational Oncology
– volume: 15
  start-page: 125
  year: 2021
  end-page: 140
  article-title: Capsaicin inhibits proliferation and induces apoptosis in breast cancer by down‐regulating FBI‐1‐mediated NF‐κB pathway
  publication-title: Drug Design, Development and Therapy
– volume: 41
  start-page: 339
  issue: 4
  year: 2021
  end-page: 348
  article-title: Plantamajoside inhibits hypoxia‐induced migration and invasion of human cervical cancer cells through the NF‐κB and PI3K/Akt pathways
  publication-title: Journal of Receptor and Signal Transduction Research
– volume: 1871
  start-page: 40
  issue: 1
  year: 2019
  end-page: 49
  article-title: NF‐kappaB‐inducing kinase in cancer
  publication-title: Biochimica et Biophysica Acta–Reviews on Cancer
– volume: 14
  start-page: 1093
  year: 2021
  end-page: 1111
  article-title: Novel strategy in breast cancer therapy: Revealing the bright side of ginsenosides
  publication-title: Current Molecular Pharmacology
– volume: 78
  year: 2021
  article-title: Lung cancer cells and their sensitivity/resistance to cisplatin chemotherapy: Role of microRNAs and upstream mediators
  publication-title: Cellular Signalling
– volume: 11
  issue: 4
  year: 2016
  article-title: Trisubstituted‐imidazoles induce apoptosis in human breast cancer cells by targeting the oncogenic PI3K/Akt/mTOR signaling pathway
  publication-title: PLoS ONE
– volume: 6
  start-page: 1741
  issue: 8
  year: 2016
  end-page: 1757
  article-title: DEC2 suppresses tumor proliferation and metastasis by regulating ERK/NF‐κB pathway in gastric cancer
  publication-title: American Journal of Cancer Research
– volume: 44
  start-page: 2621
  issue: 6
  year: 2020
  end-page: 2633
  article-title: Theabrownin inhibits the cytoskeleton‑dependent cell cycle, migration and invasion of human osteosarcoma cells through NF‑κB pathway‑related mechanisms
  publication-title: Oncology Reports
– volume: 12
  start-page: 432
  issue: 1
  year: 2021
  article-title: Dll1(+) quiescent tumor stem cells drive chemoresistance in breast cancer through NF‐κB survival pathway
  publication-title: Nature Communications
– volume: 150
  year: 2019
  article-title: Farnesol abrogates epithelial to mesenchymal transition process through regulating Akt/mTOR pathway
  publication-title: Pharmacological Research
– volume: 71
  start-page: 1262
  issue: 4
  year: 2020
  end-page: 1278
  article-title: Mesencephalic astrocyte‐derived neurotrophic factor inhibits liver cancer through small ubiquitin‐related modifier (SUMO)ylation‐related suppression of NF‐κB/snail signaling pathway and epithelial‐mesenchymal transition
  publication-title: Hepatology
– volume: 52
  start-page: 1593
  issue: 5
  year: 2018
  end-page: 1602
  article-title: Curcumin inhibits superoxide dismutase‐induced epithelial‐to‐mesenchymal transition via the PI3K/Akt/NF‐κB pathway in pancreatic cancer cells
  publication-title: International Journal of Oncology
– volume: 56
  start-page: 36
  issue: 1
  year: 2017
  end-page: 48
  article-title: Icariside II inhibits the EMT of NSCLC cells in inflammatory microenvironment via down‐regulation of Akt/NF‐κB signaling pathway
  publication-title: Molecular Carcinogenesis
– volume: 30
  start-page: 124
  issue: 2
  year: 2017
  end-page: 132
  article-title: Liver X receptor α (LXRα) promoted invasion and EMT of gastric cancer cells by regulation of NF‐κB activity
  publication-title: Human Cell
– volume: 133
  year: 2021
  article-title: Pre‐clinical investigation of STAT3 pathway in bladder cancer: Paving the way for clinical translation
  publication-title: Biomedicine & Pharmacotherapy
– volume: 12
  start-page: 25730
  issue: 24
  year: 2020
  end-page: 25743
  article-title: Cardamonin induces G2/M phase arrest and apoptosis through inhibition of NF‐κB and mTOR pathways in ovarian cancer
  publication-title: Aging
– volume: 124
  start-page: 219
  year: 2019
  end-page: 230
  article-title: suppresses invasion and metastasis in triple‐negative breast cancer cells by reversing EMT through the NF‐κB and Wnt/β‐catenin signaling pathway
  publication-title: Food and Chemical Toxicology
– volume: 21
  start-page: 393
  issue: 7
  year: 1976
  end-page: 400
  article-title: Culture and origin of epithelium‐like and fibroblast‐like cells from porcine periodontal ligament explants and cell suspensions
  publication-title: Archives of Oral Biology
– volume: 36
  start-page: 1333
  issue: 3
  year: 2016
  end-page: 1338
  article-title: Oxymatrine inhibits epithelial‐mesenchymal transition through regulation of NF‐κB signaling in colorectal cancer cells
  publication-title: Oncology Reports
– volume: 48
  start-page: 225
  issue: 1
  year: 2016
  end-page: 234
  article-title: NF‐κB signaling plays irreplaceable roles in cisplatin‐induced bladder cancer chemoresistance and tumor progression
  publication-title: International Journal of Oncology
– volume: 12
  start-page: 643
  issue: 7
  year: 2021
  article-title: Western diet leads to aging‐related tumorigenesis via activation of the inflammatory, UPR, and EMT pathways
  publication-title: Cell Death and Disease
– volume: 20
  start-page: 1039
  issue: 2
  year: 2020
  end-page: 1047
  article-title: NF‐κB interaction long non‐coding RNA inhibits migration, invasion and epithelial‐mesenchymal transition of cervical cancer cells through inhibiting NF‐κB signaling pathways
  publication-title: Experimental and Therapeutic Medicine
– volume: 109
  issue: 6
  year: 2017
  article-title: Wanted DEAD/H or alive: Helicases winding up in cancers
  publication-title: Journal of the National Cancer Institute
– volume: 288
  year: 2021
  article-title: Long non‐coding RNAs as new players in bladder cancer: Lessons from pre‐clinical and clinical studies
  publication-title: Life Sciences
– volume: 14
  start-page: 617
  issue: 5
  year: 2001
  end-page: 627
  article-title: Responses of epithelial and fibroblast‐like cells to discontinuous configuration of the culture substrate
  publication-title: Membrane & Cell Biology
– volume: 1874
  issue: 2
  year: 2020
  article-title: Pharmacological significance of the non‐canonical NF‐κB pathway in tumorigenesis
  publication-title: Biochimica et Biophysica Acta–Reviews on Cancer
– volume: 16
  start-page: 117
  issue: 1
  year: 2017
  article-title: Oncogenic miR‐210‐3p promotes prostate cancer cell EMT and bone metastasis via NF‐κB signaling pathway
  publication-title: Molecular Cancer
– volume: 52
  start-page: 1236
  issue: 5
  year: 2019
  end-page: 1250
  article-title: Chrysin inhibits proinflammatory factor‐induced EMT phenotype and cancer stem cell‐like features in hela cells by blocking the NF‐κB/twist axis
  publication-title: Cellular Physiology and Biochemistry
– volume: 9
  issue: 7
  year: 2019
  article-title: Formononetin regulates multiple oncogenic signaling cascades and enhances sensitivity to bortezomib in a multiple myeloma mouse model
  publication-title: Biomolecules
– volume: 111
  start-page: 1327
  issue: 7
  year: 2014
  end-page: 1337
  article-title: Negative regulation of signal transducer and activator of transcription‐3 signalling cascade by lupeol inhibits growth and induces apoptosis in hepatocellular carcinoma cells
  publication-title: British Journal of Cancer
– volume: 32
  start-page: 115
  issue: 4
  year: 2015
  article-title: DLC‐1 induces mitochondrial apoptosis and epithelial mesenchymal transition arrest in nasopharyngeal carcinoma by targeting EGFR/Akt/NF‐κB pathway
  publication-title: Medical Oncology
– volume: 24
  start-page: 575
  issue: 11
  year: 2016
  end-page: 589
  article-title: Nimbolide‐induced oxidative stress abrogates STAT3 signaling cascade and inhibits tumor growth in transgenic adenocarcinoma of mouse prostate model
  publication-title: Antioxidants & Redox Signaling
– volume: 161
  year: 2020
  article-title: Cancer and SOX proteins: New insight into their role in ovarian cancer progression/inhibition
  publication-title: Pharmacological Research
– volume: 431
  start-page: 123
  year: 2018
  end-page: 141
  article-title: Formononetin‐induced oxidative stress abrogates the activation of STAT3/5 signaling axis and suppresses the tumor growth in multiple myeloma preclinical model
  publication-title: Cancer Letters
– volume: 18
  start-page: 2220
  issue: 8
  year: 2012
  end-page: 2229
  article-title: First evidence that γ‐tocotrienol inhibits the growth of human gastric cancer and chemosensitizes it to capecitabine in a xenograft mouse model through the modulation of NF‐κB pathway
  publication-title: Clinical Cancer Research
– volume: 260
  year: 2021
  article-title: Biomedical application of chitosan‐based nanoscale delivery systems: Potential usefulness in siRNA delivery for cancer therapy
  publication-title: Carbohydrate Polymers
– volume: 27
  start-page: 1793
  issue: 9
  year: 2013
  end-page: 1802
  article-title: RUNX1 meets MLL: Epigenetic regulation of hematopoiesis by two leukemia genes
  publication-title: Leukemia
– volume: 22
  issue: 11
  year: 2021
  article-title: Epithelial‐mesenchymal transition (EMT) induced by TGF‐β in hepatocellular carcinoma cells reprograms lipid metabolism
  publication-title: International Journal of Molecular Sciences
– volume: 14
  issue: 9
  year: 2021
  article-title: SOS1 promotes epithelial‐mesenchymal transition of Epithelial Ovarian Cancer (EOC) cells through AKT independent NF‐κB signaling pathway
  publication-title: Translational Oncology
– volume: 90
  start-page: 677
  year: 2017
  end-page: 685
  article-title: Baicalein increases cisplatin sensitivity of A549 lung adenocarcinoma cells via PI3K/Akt/NF‐κB pathway
  publication-title: Biomedicine & Pharmacotherapy
– volume: 21
  start-page: 640
  issue: 8
  year: 2021
  end-page: 665
  article-title: Crosstalk of long non‐coding RNAs and EMT: Searching the missing pieces of an incomplete puzzle for lung cancer therapy
  publication-title: Current Cancer Drug Targets
– volume: 16
  start-page: 495
  issue: 3
  year: 2020
  end-page: 503
  article-title: NKILA, a prognostic indicator, inhibits tumor metastasis by suppressing NF‐κB/Slug mediated epithelial‐mesenchymal transition in hepatocellular carcinoma
  publication-title: International Journal of Biological Sciences
– volume: 13
  start-page: 549
  issue: 4
  year: 2019
  end-page: 560
  article-title: MiR‐873‐5p suppresses cell proliferation and epithelial‐mesenchymal transition via directly targeting Jumonji domain‐containing protein 8 through the NF‐κB pathway in colorectal cancer
  publication-title: Journal of Cell Communication and Signaling
– volume: 53
  start-page: 2241
  issue: 5
  year: 2018
  end-page: 2257
  article-title: miR‐17‐92 functions as an oncogene and modulates NF‐κB signaling by targeting TRAF3 in MGC‐803 human gastric cancer cells
  publication-title: International Journal of Oncology
– volume: 908
  year: 2021
  article-title: The involvement of epithelial‐to‐mesenchymal transition in doxorubicin resistance: Possible molecular targets
  publication-title: European Journal of Pharmacology
– volume: 6
  start-page: 1399
  issue: 6
  year: 2017
  end-page: 1408
  article-title: Epigenetic silencing of ADAMTS18 promotes cell migration and invasion of breast cancer through AKT and NF‐κB signaling
  publication-title: Cancer Medicine
– volume: 582
  start-page: 1821
  issue: 13
  year: 2008
  end-page: 1828
  article-title: A novel anticancer effect of butein: inhibition of invasion through the ERK1/2 and NF‐kappa B signaling pathways in bladder cancer cells
  publication-title: FEBS Letters
– volume: 110
  start-page: 2286
  issue: 7
  year: 2007
  end-page: 2295
  article-title: Salinosporamide A (NPI‐0052) potentiates apoptosis, suppresses osteoclastogenesis, and inhibits invasion through down‐modulation of NF‐kappaB regulated gene products
  publication-title: Blood
– volume: 790
  year: 2021
  article-title: Low‐dose mono(2‐ethylhexyl) phthalate promotes ovarian cancer development through PPARα‐dependent PI3K/Akt/NF‐κB pathway
  publication-title: Science of the Total Environment
– volume: 41
  start-page: 26
  year: 2021
  end-page: 36
  article-title: Complete loss of miR‐200 family induces EMT associated cellular senescence in gastric cancer
  publication-title: Oncogene
– volume: 39
  issue: 7
  year: 2019
  article-title: Long noncoding RNA FAM3D‐AS1 inhibits development of colorectal cancer through NF‐κB signaling pathway
  publication-title: Bioscience Reports
– volume: 39
  issue: 5
  year: 2019
  article-title: Apigenin inhibits epithelial‐mesenchymal transition of human colon cancer cells through NF‐κB/Snail signaling pathway
  publication-title: Bioscience Reports
– volume: 20
  start-page: 277
  year: 2020
  article-title: Flaming the fight against cancer cells: The role of microRNA‐93
  publication-title: Cancer Cell International
– volume: 2021
  year: 2021
  article-title: Berbamine suppresses the progression of bladder cancer by modulating the ROS/NF‐κB axis
  publication-title: Oxidative Medicine and Cellular Longevity
– volume: 23
  year: 2021
  article-title: MicroRNAs regulating SOX2 in cancer progression and therapy response
  publication-title: Expert Reviews in Molecular Medicine
– volume: 62
  start-page: 313
  issue: 3
  year: 2021
  end-page: 324
  article-title: mir‐21‐5p inhibits the progression of human chondrosarcoma by regulating CCR7/STAT3/NF‐κB pathway
  publication-title: Connective Tissue Research
– volume: 22
  issue: 21
  year: 2021
  article-title: Targeting cancer stem cells by dietary agents: An important therapeutic strategy against human malignancies
  publication-title: International Journal of Molecular Sciences
– volume: 20
  start-page: 290
  year: 2021
  end-page: 305
  article-title: miR‐19a/b promote EMT and proliferation in glioma cells via SEPT7‐AKT‐NF‐κB pathway
  publication-title: Molecular Therapy—Oncolytics
– volume: S1044–1579X
  start-page: 00210
  issue: 1021
  year: 2021
  end-page: 00218
  article-title: Long non‐coding RNAs regulated NF‐κB signaling in cancer metastasis: Micromanaging by not so small non‐coding RNAs
  publication-title: Seminars in Cancer Biology
– volume: 261
  year: 2020
  article-title: Orai‐1 and Orai‐2 regulate oral cancer cell migration and colonisation by suppressing Akt/mTOR/NF‐κB signalling
  publication-title: Life Sciences
– volume: 2019
  year: 2019
  article-title: Oroxylin A suppresses the cell proliferation, migration, and EMT via NF‐κB signaling pathway in human breast cancer cells
  publication-title: BioMed Research International
– volume: 42
  start-page: 2221
  issue: 4
  year: 2018
  end-page: 2228
  article-title: Melatonin inhibits epithelial‑to‑mesenchymal transition in gastric cancer cells via attenuation of IL‑1β/NF‑κB/MMP2/MMP9 signaling
  publication-title: International Journal of Molecular Medicine
– volume: 21
  issue: 11
  year: 2020
  article-title: Association of the epithelial‐mesenchymal transition (EMT) with cisplatin resistance
  publication-title: International Journal of Molecular Sciences
– volume: 647
  start-page: 37
  year: 2009
  end-page: 51
  article-title: Targeting TNF for treatment of cancer and autoimmunity
  publication-title: Advances in Experimental Medicine and Biology
– volume: 19
  start-page: 728
  issue: 1
  year: 2019
  article-title: Metformin reverses mesenchymal phenotype of primary breast cancer cells through STAT3/NF‐κB pathways
  publication-title: BMC Cancer
– volume: 354
  start-page: 153
  issue: 1
  year: 2014
  end-page: 163
  article-title: Bergamottin, a natural furanocoumarin obtained from grapefruit juice induces chemosensitization and apoptosis through the inhibition of STAT3 signaling pathway in tumor cells
  publication-title: Cancer Letters
– volume: 394
  issue: 2
  year: 2020
  article-title: The MyD88 inhibitor TJ‐M2010‐2 suppresses proliferation, migration and invasion of breast cancer cells by regulating MyD88/GSK‐3β and MyD88/NF‐κB signalling pathways
  publication-title: Experimental Cell Research
– volume: 48
  start-page: 1335
  issue: 2
  year: 2021
  end-page: 1343
  article-title: Regulation of valproic acid induced EMT by AKT/GSK3β/β‐catenin signaling pathway in triple negative breast cancer
  publication-title: Molecular Biology Reports
– volume: 295
  start-page: 214
  issue: 2
  year: 2010
  end-page: 228
  article-title: NF‐kappaB promotes epithelial‐mesenchymal transition, migration and invasion of pancreatic carcinoma cells
  publication-title: Cancer Letters
– volume: 6
  start-page: 28752
  issue: 43
  year: 2021
  end-page: 28769
  article-title: Chitosan‐decorated PLGA‐NPs loaded with tannic acid/vitamin E mitigate colon cancer via the NF‐κB/β‐Cat/EMT pathway
  publication-title: ACS Omega
– volume: 10
  issue: 3
  year: 2021
  article-title: Nrf2 signaling pathway in chemoprotection and doxorubicin resistance: Potential application in drug discovery
  publication-title: Antioxidants
– volume: 129
  start-page: 1552
  issue: 7
  year: 2011
  end-page: 1563
  article-title: Inhibition of CXCR4/CXCL12 signaling axis by ursolic acid leads to suppression of metastasis in transgenic adenocarcinoma of mouse prostate model
  publication-title: International Journal of Cancer
– volume: 44
  start-page: 382
  issue: 1
  year: 2020
  end-page: 392
  article-title: Curcumin inhibits pancreatic cancer cell invasion and EMT by interfering with tumor‑stromal crosstalk under hypoxic conditions via the IL‑6/ERK/NF‑κB axis
  publication-title: Oncology Reports
– volume: 12
  start-page: 80
  issue: 1
  year: 2019
  end-page: 105
  article-title: Ubenimex induces autophagy inhibition and EMT suppression to overcome cisplatin resistance in GC cells by perturbing the CD13/EMP3/PI3K/AKT/NF‐κB axis
  publication-title: Aging
– volume: 144
  year: 2021
  article-title: Cervical cancer progression is regulated by SOX transcription factors: Revealing signaling networks and therapeutic strategies
  publication-title: Biomedicine & Pharmacotherapy
– volume: 58
  start-page: 51
  issue: 1
  year: 2020
  end-page: 59
  article-title: Methyl lucidone induces apoptosis and G(2)/M phase arrest via the PI3K/Akt/NF‐κB pathway in ovarian cancer cells
  publication-title: Pharmaceutical Biology
– volume: 8
  year: 2020
  article-title: Apigenin as tumor suppressor in cancers: Biotherapeutic activity, nanodelivery, and mechanisms with emphasis on pancreatic cancer
  publication-title: Frontiers in Chemistry
– volume: 12
  start-page: 1
  issue: 1
  year: 2017
  end-page: 10
  article-title: Targeting multiple oncogenic pathways for the treatment of hepatocellular carcinoma
  publication-title: Targeted Oncology
– volume: 54
  issue: 12
  year: 2021
  article-title: Circular RNAs in cell cycle regulation: Mechanisms to clinical significance
  publication-title: Cell Proliferation
– volume: 12
  start-page: 611
  issue: 1
  year: 2020
  end-page: 627
  article-title: Aspirin enhances the sensitivity of colon cancer cells to cisplatin by abrogating the binding of NF‐κB to the COX‐2 promoter
  publication-title: Aging
– volume: 26
  start-page: 711
  issue: 5
  year: 2007
  end-page: 724
  article-title: NF‐kappaB represses E‐cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: Potential involvement of ZEB‐1 and ZEB‐2
  publication-title: Oncogene
– volume: 1805
  start-page: 167
  issue: 2
  year: 2010
  end-page: 180
  article-title: Targeting transcription factor NF‐kappaB to overcome chemoresistance and radioresistance in cancer therapy
  publication-title: Biochimica et Biophysica Acta
– volume: 41
  start-page: 123
  issue: 1
  year: 2021
  end-page: 130
  article-title: Lenvatinib inhibits AKT/NF‐κB signaling and induces apoptosis through extrinsic/intrinsic pathways in non‐small cell lung cancer
  publication-title: Anticancer Research
– volume: 7
  year: 2016
  article-title: Judicious toggling of mTOR activity to combat insulin resistance and cancer: Current evidence and perspectives
  publication-title: Frontiers in Pharmacology
– volume: 9
  start-page: 3183
  issue: 1
  year: 2018
  article-title: Structural basis for reactivating the mutant TERT promoter by cooperative binding of p52 and ETS1
  publication-title: Nature Communications
– volume: 12
  issue: 8
  year: 2020
  article-title: Targeting NF‐κB signaling for multiple myeloma
  publication-title: Cancers
– volume: 9
  issue: 8
  year: 2021
  article-title: NF‐κB in gastric cancer development and therapy
  publication-title: Biomedicines
– volume: 362
  start-page: 8
  issue: 1
  year: 2015
  end-page: 14
  article-title: Garcinol: Current status of its anti‐oxidative, anti‐inflammatory and anti‐cancer effects
  publication-title: Cancer Letters
– volume: 86
  year: 2021
  article-title: LncRNA CCAT1 sponges miR‐218‐5p to promote EMT, cellular migration and invasion of retinoblastoma by targeting MTF2
  publication-title: Cellular Signalling
– volume: 881
  year: 2020
  article-title: PTEN: What we know of the function and regulation of this onco‐suppressor factor in bladder cancer?
  publication-title: European Journal of Pharmacology
– volume: 9
  issue: 8
  year: 2021
  article-title: NF‐κB and human cancer: What have we learned over the past 35 years?
  publication-title: Biomedicines
– volume: 509
  start-page: 63
  year: 2021
  end-page: 80
  article-title: Regulation of nuclear factor‐Kappa B (NF‐κB) signaling pathway by non‐coding RNAs in cancer: Inhibiting or promoting carcinogenesis?
  publication-title: Cancer Letters
– volume: 75
  start-page: 907
  issue: 4
  year: 2008
  end-page: 913
  article-title: Reversal of chemoresistance and enhancement of apoptosis by statins through down‐regulation of the NF‐kappaB pathway
  publication-title: Biochemical Pharmacology
– volume: 9
  year: 2018
  article-title: N‐substituted Pyrido‐1,4‐Oxazin‐3‐Ones induce apoptosis of hepatocellular carcinoma cells by targeting NF‐κB signaling pathway
  publication-title: Frontiers in Pharmacology
– volume: 166
  start-page: 485
  issue: 6
  year: 2019
  end-page: 493
  article-title: ZBTB7A promotes migration, invasion and metastasis of human breast cancer cells through NF‐κB‐induced epithelial‐mesenchymal transition in vitro and in vivo
  publication-title: Journal of Biochemistry
– volume: 22
  start-page: 414
  issue: 5
  year: 2016
  end-page: 429
  article-title: Noncanonical NF‐κB signaling in health and disease
  publication-title: Trends in Molecular Medicine
– volume: 40
  start-page: 805
  issue: 6
  year: 2019
  end-page: 818
  article-title: The metastasis suppressor, NDRG1, attenuates oncogenic TGF‐β and NF‐κB signaling to enhance membrane E‐cadherin expression in pancreatic cancer cells
  publication-title: Carcinogenesis
– volume: 1871
  start-page: 12
  issue: 1
  year: 2019
  end-page: 19
  article-title: Role of tumor‐derived exosomes in cancer metastasis
  publication-title: Biochimica et Biophysica Acta ‐ Reviews on Cancer
– volume: 7
  issue: 5
  year: 2018
  article-title: PD‐L1 expression is regulated by both DNA methylation and NF‐κB during EMT signaling in non‐small cell lung carcinoma
  publication-title: Oncoimmunology
– volume: 8
  issue: 10
  year: 2019
  article-title: Insights into biological role of LncRNAs in epithelial‐mesenchymal transition
  publication-title: Cells
– volume: 6
  start-page: 5147
  issue: 7
  year: 2015
  end-page: 5163
  article-title: Garcinol sensitizes human head and neck carcinoma to cisplatin in a xenograft mouse model despite downregulation of proliferative biomarkers
  publication-title: Oncotarget
– volume: 8
  start-page: 1067
  issue: 3
  year: 2017
  end-page: 1079
  article-title: Garcinol sensitizes breast cancer cells to Taxol through the suppression of caspase‐3/iPLA(2) and NF‐κB/Twist1 signaling pathways in a mouse 4T1 breast tumor model
  publication-title: Food and Function
– volume: 49
  issue: 3
  year: 2021
  article-title: Diallyl trisulfide inhibited tobacco smoke‐mediated bladder EMT and cancer stem cell marker expression via the NF‐κB pathway in vivo
  publication-title: Journal of International Medical Research
– volume: 485
  start-page: 38
  year: 2020
  end-page: 44
  article-title: Non‐coding RNA in bladder cancer
  publication-title: Cancer Letters
– volume: 277
  year: 2021
  article-title: Employing siRNA tool and its delivery platforms in suppressing cisplatin resistance: Approaching to a new era of cancer chemotherapy
  publication-title: Life Sciences
– volume: 589
  start-page: 974
  issue: 9
  year: 2015
  end-page: 984
  article-title: Quantitative assessment of telomerase components in cancer cell lines
  publication-title: FEBS Letters
– volume: 11
  start-page: 479
  issue: 2
  year: 2021
  end-page: 494
  article-title: Elevated HMGB1 expression induced by hepatitis B virus X protein promotes epithelial‐mesenchymal transition and angiogenesis through STAT3/miR‐34a/NF‐κB in primary liver cancer
  publication-title: American Journal of Cancer Research
– volume: 246
  start-page: 379
  issue: 1
  year: 2012
  end-page: 400
  article-title: NF‐κB and the link between inflammation and cancer
  publication-title: Immunological Reviews
– volume: 10
  issue: 10
  year: 2020
  article-title: Broad‐spectrum preclinical antitumor activity of chrysin: Current trends and future perspectives
  publication-title: Biomolecules
– volume: 892
  year: 2021
  article-title: MicroRNA‐mediated autophagy regulation in cancer therapy: The role in chemoresistance/chemosensitivity
  publication-title: European Journal of Pharmacology
– volume: 11
  start-page: 464
  issue: 5–6
  year: 2017
  end-page: 475
  article-title: Osthole inhibited TGF β‐induced epithelial‐mesenchymal transition (EMT) by suppressing NF‐κB mediated Snail activation in lung cancer A549 cells
  publication-title: Cell Adhesion & Migration
– volume: 132
  year: 2020
  article-title: NF‐κB/miR‐18a‐3p and miR‐4286/BZRAP1 axis may mediate carcinogenesis in ‐associated gastric cancer
  publication-title: Biomedicine & Pharmacotherapy
– volume: 37
  start-page: 2913
  issue: 5
  year: 2017
  end-page: 2919
  article-title: Inhibition of CCR7 promotes NF‐κB‐dependent apoptosis and suppresses epithelial‐mesenchymal transition in non‐small cell lung cancer
  publication-title: Oncology Reports
– volume: 524
  start-page: 803
  issue: 4
  year: 2020
  end-page: 809
  article-title: Inhibition of arachidonate lipoxygenase12 targets lung cancer through inhibiting EMT and suppressing RhoA and NF‐κB activity
  publication-title: Biochemical and Biophysical Research Communications
– volume: 39
  start-page: 2721
  issue: 6
  year: 2018
  end-page: 2730
  article-title: NIK‑ and IKKβ‑binding protein contributes to gastric cancer chemoresistance by promoting epithelial‑mesenchymal transition through the NF‑κB signaling pathway
  publication-title: Oncology Reports
– volume: 9
  start-page: 6771
  issue: 6
  year: 2018
  end-page: 6779
  article-title: Kanglaite inhibits EMT caused by TNF‐α via NF‐κΒ inhibition in colorectal cancer cells
  publication-title: Oncotarget
– volume: 14
  start-page: 407
  issue: 2
  year: 2020
  end-page: 425
  article-title: TGFβ1‐induced beta‐site APP‐cleaving enzyme 2 upregulation promotes tumorigenesis through the NF‐κB signalling pathway in human gliomas
  publication-title: Molecular Oncology
– volume: 157
  year: 2021
  article-title: Gallic acid for cancer therapy: Molecular mechanisms and boosting efficacy by nanoscopical delivery
  publication-title: Food and Chemical Toxicology
– volume: 120
  start-page: 4504
  issue: 3
  year: 2019
  end-page: 4513
  article-title: Oleuropein induces apoptosis via abrogating NF‐κB activation cascade in estrogen receptor‐negative breast cancer cells
  publication-title: Journal of Cellular Biochemistry
– volume: 17
  start-page: 1940
  issue: 8
  year: 2021
  end-page: 1952
  article-title: MicroRNA‐135b/CAMK2D axis contribute to malignant progression of gastric cancer through EMT process remodeling
  publication-title: International Journal of Biological Sciences
– volume: 121
  start-page: 31
  issue: 1
  year: 2020
  end-page: 36
  article-title: ZEB1 and ZEB2 gene editing mediated by CRISPR/Cas9 in A549 cell line
  publication-title: Bratislavske Lekarske Listy
– volume: 70
  start-page: 1857
  issue: 10
  year: 2021
  end-page: 1871
  article-title: NAIL: An evolutionarily conserved lncRNA essential for licensing coordinated activation of p38 and NFκB in colitis
  publication-title: Gut
– volume: 29
  start-page: 331
  issue: 3
  year: 2021
  end-page: 341
  article-title: SP‐8356, a (1S)‐(‐)‐verbenone derivative, inhibits the growth and motility of liver cancer cells by regulating NF‐κB and ERK signaling
  publication-title: Biomolecules & Therapeutics
– volume: 11
  issue: 6
  year: 2021
  article-title: Overview of evidence‐based chemotherapy for oral cancer: Focus on drug resistance related to the epithelial‐mesenchymal transition
  publication-title: Biomolecules
– volume: 171
  year: 2021
  article-title: Caffeic acid and its derivatives as potential modulators of oncogenic molecular pathways: New hope in the fight against cancer
  publication-title: Pharmacological Research
– volume: 12
  start-page: 1063
  issue: 11
  year: 2021
  article-title: Circ_0058106 promotes proliferation, metastasis and EMT process by regulating Wnt2b/β‐catenin/c‐Myc pathway through miR‐185‐3p in hypopharyngeal squamous cell carcinoma
  publication-title: Cell Death and Disease
– volume: 111
  start-page: 4242
  issue: 11
  year: 2020
  end-page: 4256
  article-title: Icariin‐induced inhibition of SIRT6/NF‐κB triggers redox mediated apoptosis and enhances anti‐tumor immunity in triple‐negative breast cancer
  publication-title: Cancer Science
– volume: 21
  start-page: 142
  issue: 2
  year: 2021
  end-page: 150
  article-title: Resveratrol induces apoptosis and attenuates proliferation of MCF‐7 cells in combination with radiation and hyperthermia
  publication-title: Current Molecular Medicine
– volume: 46
  start-page: 355
  issue: 1
  year: 2019
  end-page: 369
  article-title: Curcumin prevented human autocrine growth hormone (GH) signaling mediated NF‐κB activation and miR‐183‐96‐182 cluster stimulated epithelial mesenchymal transition in T47D breast cancer cells
  publication-title: Molecular Biology Reports
– volume: 18
  start-page: 309
  issue: 5
  year: 2018
  end-page: 324
  article-title: NF‐κB, inflammation, immunity and cancer: coming of age
  publication-title: Nature Reviews Immunology
– volume: 13
  issue: 7
  year: 2021
  article-title: Quercetin and its nano‐scale delivery systems in prostate cancer therapy: Paving the way for cancer elimination and reversing chemoresistance
  publication-title: Cancers
– volume: 82
  year: 2021
  article-title: Ectopic expression of microRNA‐874 represses epithelial mesenchymal transition through the NF‐κB pathway via CCNE1 in cholangiocarcinoma
  publication-title: Cellular Signalling
– volume: 9
  issue: 6
  year: 2020
  article-title: STAT3 pathway in gastric cancer: Signaling, therapeutic targeting and future prospects
  publication-title: Biology
– volume: 526
  start-page: 497
  issue: 2
  year: 2020
  end-page: 504
  article-title: Engeletin suppresses cervical carcinogenesis in vitro and in vivo by reducing NF‐κB‐dependent signaling
  publication-title: Biochemical and Biophysical Research Communications
– volume: 15
  start-page: 6873
  issue: 5
  year: 2018
  end-page: 6880
  article-title: Simultaneous stimulation with tumor necrosis factor‐α and transforming growth factor‐β1 induces epithelial‐mesenchymal transition in colon cancer cells via the NF‐κB pathway
  publication-title: Oncology Letters
– volume: 6
  start-page: 843
  issue: 8
  year: 2013
  end-page: 854
  article-title: Garcinol, a polyisoprenylated benzophenone modulates multiple proinflammatory signaling cascades leading to the suppression of growth and survival of head and neck carcinoma
  publication-title: Cancer Prevention Research
– volume: 13
  start-page: 3265
  year: 2020
  end-page: 3276
  article-title: Long non‐coding RNA‐NEAT1 promotes cell migration and invasion via regulating miR‐124/NF‐κB pathway in cervical cancer
  publication-title: OncoTargets and Therapy
– volume: 11
  start-page: 163
  issue: 1
  year: 2021
  article-title: AKR1B10 promotes breast cancer cell proliferation and migration via the PI3K/AKT/NF‐κB signaling pathway
  publication-title: Cell & Bioscience
– volume: 268
  year: 2021
  article-title: The role of microRNA‐338‐3p in cancer: Growth, invasion, chemoresistance, and mediators
  publication-title: Life Sciences
– volume: 37
  start-page: 201
  issue: 1
  year: 2016
  end-page: 209
  article-title: MiR‐491 attenuates cancer stem cells‐like properties of hepatocellular carcinoma by inhibition of GIT‐1/NF‐κB‐mediated EMT
  publication-title: Tumor Biology
– volume: 34
  start-page: 1888
  issue: 6
  year: 2021
  end-page: 1898
  article-title: Overexpression of SMC4 predicts a poor prognosis in cervical cancer and facilitates cancer cell malignancy phenotype by activating NF‐κB pathway
  publication-title: Human Cell
– volume: 11
  issue: 8
  year: 2016
  article-title: CCL21/CCR7 axis contributed to CD133+ pancreatic cancer stem‐like cell metastasis via EMT and Erk/NF‐κB pathway
  publication-title: PLoS ONE
– volume: 2019
  year: 2019
  article-title: Ursolic acid inhibits epithelial‐mesenchymal transition through the Axl/NF‐κB pathway in gastric cancer cells
  publication-title: Evidence‐Based Complementary and Alternative Medicine
– volume: 8
  year: 2018
  article-title: Novel 1,3,4‐oxadiazole induces anticancer activity by targeting NF‐κB in hepatocellular carcinoma cells
  publication-title: Frontiers in Oncology
– volume: 4
  start-page: 26
  year: 2018
  article-title: Sotetsuflavone suppresses invasion and metastasis in non‐small‐cell lung cancer A549 cells by reversing EMT via the TNF‐α/NF‐κB and PI3K/AKT signaling pathway
  publication-title: Cell Death Discovery
– volume: 8
  issue: 8
  year: 2020
  article-title: PTEN, a barrier for proliferation and metastasis of gastric cancer cells: From molecular pathways to targeting and regulation
  publication-title: Biomedicines
– volume: 140
  year: 2021
  article-title: MiR‐410‐3p activates the NF‐κB pathway by targeting ZCCHC10 to promote migration, invasion and EMT of colorectal cancer
  publication-title: Cytokine+
– volume: 72
  start-page: 1264
  issue: 8
  year: 2020b
  end-page: 1275
  article-title: MicroRNAs mediate the anti‐tumor and protective effects of ginsenosides
  publication-title: Nutrition and Cancer
– volume: 6
  year: 2016
  article-title: DYT‐40, a novel synthetic 2‐styryl‐5‐nitroimidazole derivative, blocks malignant glioblastoma growth and invasion by inhibiting AEG‐1 and NF‐κB signaling pathways
  publication-title: Scientific Reports
– volume: 24
  start-page: 1202
  issue: 3
  year: 2020
  end-page: 1210
  article-title: MicroRNA‐429 inhibits the proliferation and migration of esophageal squamous cell carcinoma cells by targeting RAB23 through the NF‐κB pathway
  publication-title: European Review for Medical and Pharmacological Sciences
– volume: 26
  issue: 8
  year: 2021
  article-title: Elucidating role of reactive oxygen species (ROS) in cisplatin chemotherapy: A focus on molecular pathways and possible therapeutic strategies
  publication-title: Molecules
– volume: 22
  start-page: 3215
  issue: 6
  year: 2018
  end-page: 3222
  article-title: Alpha B‐crystallin promotes the invasion and metastasis of gastric cancer via NF‐κB‐induced epithelial‐mesenchymal transition
  publication-title: Journal of Cellular and Molecular Medicine
– volume: 9
  start-page: 1664
  issue: 8
  year: 2019
  end-page: 1681
  article-title: Tannic acid attenuates the formation of cancer stem cells by inhibiting NF‐κB‐mediated phenotype transition of breast cancer cells
  publication-title: American Journal of Cancer Research
– volume: 32
  start-page: 394
  issue: 4
  year: 2021
  end-page: 404
  article-title: Brusatol reverses lipopolysaccharide‐induced epithelial‐mesenchymal transformation and induces apoptosis through PI3K/Akt/NF‐кB pathway in human gastric cancer SGC‐7901 cells
  publication-title: Anti‐Cancer Drugs
– volume: 10
  issue: 1
  year: 2019
  article-title: The emerging role of long non‐coding RNAs in the metastasis of hepatocellular carcinoma
  publication-title: Biomolecules
– volume: 5
  start-page: 1169
  issue: 3
  year: 2015
  end-page: 1179
  article-title: Interleukin‐17‐induced EMT promotes lung cancer cell migration and invasion via NF‐κB/ZEB1 signal pathway
  publication-title: American Journal of Cancer Research
– volume: 12
  start-page: 101
  issue: 1
  year: 2019
  end-page: 112
  article-title: NF‐κB/Twist axis is involved in chysin inhibition of ovarian cancer stem cell features induced by co‐treatment of TNF‐α and TGF‐β
  publication-title: International Journal of Clinical and Experimental Pathology
– volume: 80
  start-page: 1553
  issue: 10
  year: 2010
  end-page: 1562
  article-title: Butein downregulates chemokine receptor CXCR4 expression and function through suppression of NF‐κB activation in breast and pancreatic tumor cells
  publication-title: Biochemical Pharmacology
– volume: 37
  start-page: 1873
  issue: 3
  year: 2017
  end-page: 1882
  article-title: Exposure to TNF‑α combined with TGF‑β induces carcinogenesis in vitro via NF‐κB/Twist axis
  publication-title: Oncology Reports
– volume: 191
  start-page: 727
  year: 2021
  end-page: 737
  article-title: Revealing the role of miRNA‐489 as a new onco‐suppressor factor in different cancers based on pre‐clinical and clinical evidence
  publication-title: International Journal of Biological Macromolecules
– volume: 114
  start-page: 520
  issue: 4
  year: 2016
  end-page: 527
  article-title: Knockdown of NDRG1 promote epithelial‐mesenchymal transition of colorectal cancer via NF‐κB signaling
  publication-title: Journal of Surgical Oncology
– volume: 26
  start-page: 475
  issue: 5
  year: 2015
  end-page: 486
  article-title: Silymarin and hepatocellular carcinoma: A systematic, comprehensive, and critical review
  publication-title: Anti‐Cancer Drugs
– volume: 183
  start-page: 681
  year: 2021
  end-page: 694
  article-title: Interplay between SOX9 transcription factor and microRNAs in cancer
  publication-title: International Journal of Biological Macromolecules
– volume: 476
  start-page: 1575
  issue: 3
  year: 2021
  end-page: 1588
  article-title: MiR‐182 inhibits proliferation, migration, invasion and inflammation of endometrial stromal cells through deactivation of NF‐κB signaling pathway in endometriosis
  publication-title: Molecular and Cellular Biochemistry
– volume: 36
  start-page: 189
  year: 2021
  end-page: 213
  article-title: Curcumin and its derivatives in cancer therapy: Potentiating antitumor activity of cisplatin and reducing side effects
  publication-title: Phytotherapy Research
– volume: 92
  start-page: 267
  issue: 3
  year: 2014
  end-page: 276
  article-title: Simvastatin sensitizes human gastric cancer xenograft in nude mice to capecitabine by suppressing nuclear factor‐kappa B‐regulated gene products
  publication-title: Journal of Molecular Medicine
– volume: 256
  year: 2020
  article-title: Magnoflorine inhibits the malignant phenotypes and increases cisplatin sensitivity of osteosarcoma cells via regulating miR‐410‐3p/HMGB1/NF‐κB pathway
  publication-title: Life Sciences
– volume: 40
  start-page: 1458
  issue: 8
  year: 2021
  end-page: 1475
  article-title: Hypoxia‐induced PLOD1 overexpression contributes to the malignant phenotype of glioblastoma via NF‐κB signaling
  publication-title: Oncogene
– volume: 147
  year: 2019
  article-title: Anti‐cancer effects of oxymatrine are mediated through multiple molecular mechanism(s) in tumor models
  publication-title: Pharmacological Research
– volume: 12
  issue: 1
  year: 2017
  article-title: NF‐kappa B is involved in the regulation of EMT genes in breast cancer cells
  publication-title: PLoS ONE
– volume: 45
  start-page: 115
  issue: 6
  year: 2021
  article-title: Schisandrin B inhibits epithelial‑mesenchymal transition and stemness of large‑cell lung cancer cells and tumorigenesis in xenografts via inhibiting the NF‑κB and p38 MAPK signaling pathways
  publication-title: Oncology Reports
– volume: 25
  start-page: 4487
  issue: 9
  year: 2021
  end-page: 4500
  article-title: FABP5 enhances malignancies of lower‐grade gliomas via canonical activation of NF‐κB signaling
  publication-title: Journal of Cellular and Molecular Medicine
– volume: 12
  start-page: 5394
  issue: 18
  year: 2021
  end-page: 5403
  article-title: MiR‐301a‐5p/SCIN promotes gastric cancer progression via regulating STAT3 and NF‐κB signaling
  publication-title: Journal of Cancer
– volume: 24
  start-page: 622
  issue: 3
  year: 2021
  article-title: Interference with KCNJ2 inhibits proliferation, migration and EMT progression of apillary thyroid carcinoma cells by upregulating GNG2 expression
  publication-title: Molecular Medicine Reports
– volume: 237
  start-page: 199
  year: 2021
  end-page: 238
  article-title: The multidimensional role of the Wnt/β‐catenin signaling pathway in human malignancies
  publication-title: Journal of Cellular Physiology
– volume: 13
  issue: 18
  year: 2021
  article-title: NF‐κB and pancreatic cancer; chapter and verse
  publication-title: Cancers
– ident: e_1_2_13_72_1
  doi: 10.1016/j.molimm.2020.11.016
– ident: e_1_2_13_170_1
  doi: 10.1016/j.phrs.2021.105759
– ident: e_1_2_13_218_1
  doi: 10.3390/biom11060893
– ident: e_1_2_13_38_1
  doi: 10.1016/j.canlet.2021.03.018
– ident: e_1_2_13_177_1
  doi: 10.3390/antiox10030349
– ident: e_1_2_13_292_1
  doi: 10.1080/10799893.2020.1808679
– ident: e_1_2_13_97_1
  doi: 10.1038/s41419-021-03929-9
– ident: e_1_2_13_99_1
  doi: 10.18632/aging.102644
– ident: e_1_2_13_169_1
  doi: 10.1016/j.biopha.2020.111077
– ident: e_1_2_13_47_1
  doi: 10.2147/dddt.S269901
– ident: e_1_2_13_262_1
  doi: 10.3390/cancers12082203
– ident: e_1_2_13_196_1
  doi: 10.1016/j.bbcan.2020.188423
– ident: e_1_2_13_119_1
  doi: 10.3390/biomedicines9091265
– ident: e_1_2_13_121_1
  doi: 10.1158/1940-6207.Capr-13-0070
– ident: e_1_2_13_289_1
  doi: 10.1186/s12885-017-3829-9
– ident: e_1_2_13_35_1
  doi: 10.1016/j.ijbiomac.2021.04.185
– ident: e_1_2_13_155_1
  doi: 10.1016/j.canlet.2010.03.003
– ident: e_1_2_13_122_1
  doi: 10.18632/oncotarget.2881
– ident: e_1_2_13_129_1
  doi: 10.1158/1538-7445.AM2016-1741
– ident: e_1_2_13_16_1
  doi: 10.3389/fchem.2020.00829
– ident: e_1_2_13_273_1
  doi: 10.1007/s13277-015-3687-5
– ident: e_1_2_13_127_1
  doi: 10.1007/s12094-021-02594-w
– ident: e_1_2_13_220_1
  doi: 10.3389/fphar.2018.00365
– ident: e_1_2_13_55_1
  doi: 10.1016/j.tranon.2021.101160
– ident: e_1_2_13_31_1
  doi: 10.3390/ijms21114002
– ident: e_1_2_13_124_1
  doi: 10.1080/03008207.2019.1702650
– ident: e_1_2_13_59_1
  doi: 10.1038/sj.onc.1209808
– ident: e_1_2_13_89_1
  doi: 10.1002/jcp.30561
– ident: e_1_2_13_139_1
  doi: 10.1186/s13046-018-0953-6
– ident: e_1_2_13_75_1
  doi: 10.1080/19336918.2016.1259058
– ident: e_1_2_13_88_1
  doi: 10.1007/s13577-021-00603-2
– ident: e_1_2_13_286_1
  doi: 10.1038/s41419-020-03257-4
– ident: e_1_2_13_92_1
  doi: 10.7717/peerj.9559
– ident: e_1_2_13_238_1
  doi: 10.1007/s11523-016-0452-7
– ident: e_1_2_13_167_1
  doi: 10.3390/cells10123348
– ident: e_1_2_13_225_1
  doi: 10.18632/oncotarget.23645
– ident: e_1_2_13_267_1
  doi: 10.1111/cpr.13143
– ident: e_1_2_13_22_1
  doi: 10.1016/j.lfs.2021.119649
– ident: e_1_2_13_65_1
  doi: 10.3389/fonc.2021.683878
– ident: e_1_2_13_203_1
  doi: 10.3390/biomedicines6030082
– ident: e_1_2_13_77_1
  doi: 10.3892/or.2018.6348
– ident: e_1_2_13_13_1
  doi: 10.1002/jcp.29327
– ident: e_1_2_13_25_1
  doi: 10.1186/s12935-020-01349-x
– ident: e_1_2_13_107_1
  doi: 10.4062/biomolther.2020.200
– ident: e_1_2_13_123_1
  doi: 10.1007/s00204-015-1470-4
– ident: e_1_2_13_172_1
  doi: 10.1016/j.lfs.2021.119368
– ident: e_1_2_13_136_1
  doi: 10.1007/s13277-014-2899-4
– ident: e_1_2_13_78_1
  doi: 10.18632/oncotarget.3956
– ident: e_1_2_13_116_1
  doi: 10.1016/j.bbrc.2020.07.015
– ident: e_1_2_13_162_1
  doi: 10.3390/ijms18091833
– ident: e_1_2_13_271_1
  doi: 10.3892/ijo.2013.1852
– ident: e_1_2_13_247_1
  doi: 10.1016/j.canlet.2017.11.037
– ident: e_1_2_13_147_1
  doi: 10.1002/jcb.29951
– ident: e_1_2_13_113_1
  doi: 10.1038/s41467-020-20664-5
– ident: e_1_2_13_85_1
  doi: 10.1155/2021/8851763
– ident: e_1_2_13_52_1
  doi: 10.1016/j.ejphar.2020.173493
– ident: e_1_2_13_257_1
  doi: 10.1111/jcmm.16536
– ident: e_1_2_13_44_1
  doi: 10.1111/jcmm.13602
– ident: e_1_2_13_254_1
  doi: 10.1016/j.omto.2021.01.005
– ident: e_1_2_13_144_1
  doi: 10.1016/j.yexcr.2020.112157
– ident: e_1_2_13_117_1
  doi: 10.1016/j.scitotenv.2021.147990
– ident: e_1_2_13_149_1
  doi: 10.1016/j.mvr.2019.103968
– ident: e_1_2_13_179_1
  doi: 10.1007/s00018-019-03053-0
– ident: e_1_2_13_171_1
  doi: 10.3390/molecules26082382
– ident: e_1_2_13_215_1
  doi: 10.1038/sj.onc.1210544
– ident: e_1_2_13_275_1
  doi: 10.1080/13880209.2019.1701044
– ident: e_1_2_13_141_1
  doi: 10.3892/ijo.2018.4543
– ident: e_1_2_13_178_1
  doi: 10.1016/j.canlet.2021.03.025
– ident: e_1_2_13_251_1
  doi: 10.1007/s12079-020-00589-w
– ident: e_1_2_13_101_1
  doi: 10.1016/j.bmc.2018.12.042
– ident: e_1_2_13_181_1
  doi: 10.3390/biom10101374
– ident: e_1_2_13_195_1
  doi: 10.1016/j.cellsig.2021.109927
– ident: e_1_2_13_229_1
  doi: 10.1038/bjc.2014.422
– ident: e_1_2_13_281_1
  doi: 10.2147/dddt.S272323
– ident: e_1_2_13_86_1
  doi: 10.1007/s10911-018-9404-4
– ident: e_1_2_13_166_1
  doi: 10.1016/j.ejphar.2021.174344
– ident: e_1_2_13_269_1
  doi: 10.1186/s13046-020-01553-7
– ident: e_1_2_13_74_1
  doi: 10.1016/j.bbamcr.2018.01.006
– ident: e_1_2_13_287_1
  doi: 10.18632/oncotarget.20418
– ident: e_1_2_13_189_1
  doi: 10.1245/s10434-018-07132-7
– ident: e_1_2_13_234_1
  doi: 10.3390/ijms22115543
– ident: e_1_2_13_131_1
  doi: 10.3892/ijo.2018.4295
– ident: e_1_2_13_130_1
  doi: 10.3892/or.2021.8066
– ident: e_1_2_13_245_1
  doi: 10.3892/etm.2020.8752
– ident: e_1_2_13_105_1
  doi: 10.1016/j.canlet.2018.05.038
– ident: e_1_2_13_263_1
  doi: 10.1007/s11010-020-03986-2
– ident: e_1_2_13_3_1
  doi: 10.1016/j.ijbiomac.2021.02.202
– ident: e_1_2_13_176_1
  doi: 10.1016/j.lfs.2020.119005
– ident: e_1_2_13_184_1
  doi: 10.3389/fphar.2018.01125
– ident: e_1_2_13_54_1
  doi: 10.3390/cells8101178
– ident: e_1_2_13_191_1
  doi: 10.1096/fj.06-7615rev
– ident: e_1_2_13_71_1
  doi: 10.3390/biomedicines9091278
– ident: e_1_2_13_272_1
  doi: 10.3390/molecules24081584
– ident: e_1_2_13_264_1
  doi: 10.3892/or.2016.5319
– ident: e_1_2_13_146_1
  doi: 10.1111/cpr.12776
– ident: e_1_2_13_280_1
  doi: 10.1089/ars.2015.6418
– ident: e_1_2_13_30_1
  doi: 10.1016/j.cellsig.2020.109871
– ident: e_1_2_13_244_1
  doi: 10.1016/j.bbrc.2018.03.071
– ident: e_1_2_13_56_1
  doi: 10.1016/j.molmed.2017.11.003
– ident: e_1_2_13_66_1
  doi: 10.1038/s41419-018-0414-3
– ident: e_1_2_13_76_1
  doi: 10.1186/s12943-016-0564-9
– ident: e_1_2_13_230_1
  doi: 10.2174/1568009621666210601114631
– ident: e_1_2_13_274_1
  doi: 10.1016/j.canlet.2018.06.008
– ident: e_1_2_13_201_1
  doi: 10.1371/journal.pone.0169622
– ident: e_1_2_13_278_1
  doi: 10.3892/or.2020.7891
– ident: e_1_2_13_291_1
  doi: 10.1038/srep27331
– ident: e_1_2_13_57_1
  doi: 10.3390/ijms20030749
– ident: e_1_2_13_235_1
  doi: 10.3390/cancers13205135
– ident: e_1_2_13_4_1
  doi: 10.1016/j.semcancer.2021.07.015
– ident: e_1_2_13_79_1
  doi: 10.1002/med.21761
– ident: e_1_2_13_214_1
  doi: 10.2174/1871520620666200811113549
– ident: e_1_2_13_133_1
  doi: 10.1016/j.canlet.2020.04.023
– ident: e_1_2_13_202_1
  doi: 10.1016/j.biopha.2020.111214
– ident: e_1_2_13_2_1
  doi: 10.1002/ptr.7305
– volume: 12
  start-page: 101
  issue: 1
  year: 2019
  ident: e_1_2_13_125_1
  article-title: NF‐κB/Twist axis is involved in chysin inhibition of ovarian cancer stem cell features induced by co‐treatment of TNF‐α and TGF‐β
  publication-title: International Journal of Clinical and Experimental Pathology
– ident: e_1_2_13_104_1
  doi: 10.3390/biom9070262
– ident: e_1_2_13_173_1
  doi: 10.1016/j.phrs.2021.105575
– ident: e_1_2_13_228_1
  doi: 10.1016/j.phymed.2021.153492
– ident: e_1_2_13_237_1
  doi: 10.3892/ijo.2015.3256
– ident: e_1_2_13_204_1
  doi: 10.1186/s13578-021-00677-3
– ident: e_1_2_13_268_1
  doi: 10.1002/cam4.1076
– ident: e_1_2_13_256_1
  doi: 10.1016/j.lfs.2020.117967
– ident: e_1_2_13_19_1
  doi: 10.3390/biom10081159
– ident: e_1_2_13_138_1
  doi: 10.3892/ol.2019.11090
– ident: e_1_2_13_6_1
  doi: 10.1182/blood-2007-04-084996
– ident: e_1_2_13_242_1
  doi: 10.1039/c6fo01588c
– ident: e_1_2_13_34_1
  doi: 10.1002/ptr.6815
– ident: e_1_2_13_100_1
  doi: 10.3892/or.2020.7801
– ident: e_1_2_13_61_1
  doi: 10.1007/s11033-018-4479-y
– volume: 9
  start-page: 1664
  issue: 8
  year: 2019
  ident: e_1_2_13_106_1
  article-title: Tannic acid attenuates the formation of cancer stem cells by inhibiting NF‐κB‐mediated phenotype transition of breast cancer cells
  publication-title: American Journal of Cancer Research
– ident: e_1_2_13_241_1
  doi: 10.1016/j.biopha.2020.110869
– ident: e_1_2_13_43_1
  doi: 10.3389/fphar.2021.758219
– ident: e_1_2_13_24_1
  doi: 10.3390/biomedicines8080264
– ident: e_1_2_13_26_1
  doi: 10.1186/s12935-021-01773-7
– ident: e_1_2_13_154_1
  doi: 10.1016/j.cyto.2021.155433
– ident: e_1_2_13_69_1
  doi: 10.1007/s11010-019-03514-x
– ident: e_1_2_13_258_1
  doi: 10.26355/eurrev_202002_20172
– ident: e_1_2_13_240_1
  doi: 10.1042/bsr20190452
– ident: e_1_2_13_112_1
  doi: 10.1016/j.ccr.2021.214135
– ident: e_1_2_13_108_1
  doi: 10.1016/j.jgr.2017.03.008
– ident: e_1_2_13_282_1
  doi: 10.1016/j.febslet.2008.04.046
– ident: e_1_2_13_180_1
  doi: 10.3390/molecules25030689
– ident: e_1_2_13_64_1
  doi: 10.1111/j.1600-065X.2012.01099.x
– ident: e_1_2_13_165_1
  doi: 10.1042/bsr20190724
– ident: e_1_2_13_41_1
  doi: 10.1093/jnci/djw278
– ident: e_1_2_13_226_1
  doi: 10.3390/cancers13184510
– ident: e_1_2_13_32_1
  doi: 10.1016/j.fct.2021.112576
– ident: e_1_2_13_188_1
  doi: 10.1021/acsomega.1c03477
– ident: e_1_2_13_8_1
  doi: 10.1074/jbc.M601162200
– ident: e_1_2_13_94_1
  doi: 10.7150/jca.59747
– ident: e_1_2_13_261_1
  doi: 10.1016/j.bbcan.2018.10.004
– ident: e_1_2_13_174_1
  doi: 10.1016/j.lfs.2021.119948
– ident: e_1_2_13_216_1
  doi: 10.3390/nu10050645
– ident: e_1_2_13_142_1
  doi: 10.4149/neo_2021_201031N1158
– ident: e_1_2_13_260_1
  doi: 10.1038/s41388-020-01635-y
– ident: e_1_2_13_259_1
  doi: 10.1002/jcb.27535
– ident: e_1_2_13_109_1
  doi: 10.1016/j.canlet.2014.08.002
– ident: e_1_2_13_33_1
  doi: 10.1016/j.ejphar.2020.173660
– ident: e_1_2_13_126_1
  doi: 10.1155/2019/2474805
– ident: e_1_2_13_211_1
  doi: 10.18632/aging.104184
– ident: e_1_2_13_23_1
  doi: 10.2174/1871520620666200228110704
– ident: e_1_2_13_96_1
  doi: 10.3390/cancers13071602
– ident: e_1_2_13_83_1
  doi: 10.18632/aging.102598
– ident: e_1_2_13_120_1
  doi: 10.1016/j.bbcan.2010.01.002
– ident: e_1_2_13_62_1
  doi: 10.3390/ijms222111669
– ident: e_1_2_13_243_1
  doi: 10.1111/jcmm.14574
– ident: e_1_2_13_18_1
  doi: 10.1016/j.lfs.2020.119006
– ident: e_1_2_13_279_1
  doi: 10.1080/15384047.2015.1028702
– ident: e_1_2_13_40_1
  doi: 10.1016/0003-9969(76)90001-7
– ident: e_1_2_13_168_1
  doi: 10.1016/j.lfs.2021.119430
– ident: e_1_2_13_14_1
  doi: 10.1080/01635581.2019.1675722
– ident: e_1_2_13_232_1
  doi: 10.1111/cas.14648
– ident: e_1_2_13_197_1
  doi: 10.3390/molecules25102396
– ident: e_1_2_13_137_1
  doi: 10.3892/or.2016.4927
– ident: e_1_2_13_9_1
  doi: 10.1016/j.febslet.2015.02.035
– ident: e_1_2_13_253_1
  doi: 10.3727/096504016x14799180778233
– ident: e_1_2_13_192_1
  doi: 10.3389/fphar.2016.00395
– ident: e_1_2_13_29_1
  doi: 10.1016/j.lfs.2020.117973
– ident: e_1_2_13_90_1
  doi: 10.1016/j.fct.2018.12.009
– ident: e_1_2_13_67_1
  doi: 10.33594/000000084
– ident: e_1_2_13_159_1
  doi: 10.1093/jb/mvz062
– volume: 5
  start-page: 1169
  issue: 3
  year: 2015
  ident: e_1_2_13_82_1
  article-title: Interleukin‐17‐induced EMT promotes lung cancer cell migration and invasion via NF‐κB/ZEB1 signal pathway
  publication-title: American Journal of Cancer Research
– ident: e_1_2_13_28_1
  doi: 10.1016/j.phrs.2020.105159
– ident: e_1_2_13_98_1
  doi: 10.1007/s13577-016-0157-3
– ident: e_1_2_13_222_1
  doi: 10.1002/mc.22166
– ident: e_1_2_13_252_1
  doi: 10.1038/s41420-018-0026-9
– ident: e_1_2_13_160_1
  doi: 10.1097/cad.0000000000000211
– ident: e_1_2_13_250_1
  doi: 10.3892/or.2020.7523
– ident: e_1_2_13_39_1
  doi: 10.1016/j.bbrc.2020.03.091
– ident: e_1_2_13_81_1
  doi: 10.3390/biomedicines9080889
– ident: e_1_2_13_161_1
  doi: 10.1016/j.bbcan.2018.10.002
– ident: e_1_2_13_36_1
  doi: 10.3390/biology9060126
– ident: e_1_2_13_153_1
  doi: 10.1016/j.biocel.2019.01.003
– ident: e_1_2_13_193_1
  doi: 10.1007/s11033-021-06173-8
– ident: e_1_2_13_198_1
  doi: 10.1016/j.biopha.2021.112335
– ident: e_1_2_13_233_1
  doi: 10.1016/j.bbrc.2015.07.004
– ident: e_1_2_13_95_1
  doi: 10.7150/ijbs.58062
– ident: e_1_2_13_110_1
  doi: 10.1002/jcp.30590
– ident: e_1_2_13_194_1
  doi: 10.3390/antiox6010017
– ident: e_1_2_13_231_1
  doi: 10.1002/mc.22471
– ident: e_1_2_13_93_1
  doi: 10.1007/s12032-015-0564-4
– ident: e_1_2_13_37_1
  doi: 10.1016/j.ejphar.2020.173226
– ident: e_1_2_13_114_1
  doi: 10.1038/s41598-018-20724-3
– ident: e_1_2_13_276_1
  doi: 10.1038/s41388-021-02067-y
– ident: e_1_2_13_199_1
  doi: 10.1016/j.ijbiomac.2021.09.089
– ident: e_1_2_13_102_1
  doi: 10.1016/j.semcancer.2019.08.014
– ident: e_1_2_13_277_1
  doi: 10.1016/j.biopha.2017.04.001
– ident: e_1_2_13_5_1
  doi: 10.1016/j.bcp.2007.10.010
– ident: e_1_2_13_187_1
  doi: 10.3390/biom11010015
– ident: e_1_2_13_208_1
  doi: 10.1038/s41388-019-0848-9
– ident: e_1_2_13_135_1
  doi: 10.3892/ol.2018.8230
– ident: e_1_2_13_111_1
  doi: 10.1038/leu.2013.200
– ident: e_1_2_13_152_1
  doi: 10.1007/s00210-019-01671-w
– ident: e_1_2_13_10_1
  doi: 10.1136/gutjnl-2020-322980
– ident: e_1_2_13_224_1
  doi: 10.2147/ott.S220306
– ident: e_1_2_13_150_1
  doi: 10.1002/jso.24348
– ident: e_1_2_13_115_1
  doi: 10.1016/j.phrs.2019.104504
– ident: e_1_2_13_284_1
  doi: 10.3892/or.2017.5524
– ident: e_1_2_13_80_1
  doi: 10.1177/0300060521992900
– ident: e_1_2_13_185_1
  doi: 10.1371/journal.pone.0153155
– ident: e_1_2_13_53_1
  doi: 10.7150/thno.26687
– ident: e_1_2_13_186_1
  doi: 10.1016/j.bbcan.2020.188449
– ident: e_1_2_13_73_1
  doi: 10.2174/1874467214666210203211312
– ident: e_1_2_13_140_1
  doi: 10.1016/j.canlet.2015.03.019
– ident: e_1_2_13_239_1
  doi: 10.1038/nri.2017.142
– ident: e_1_2_13_143_1
  doi: 10.1002/hep.30917
– ident: e_1_2_13_132_1
  doi: 10.3892/or.2020.7600
– ident: e_1_2_13_46_1
  doi: 10.1016/j.bbrc.2020.01.166
– ident: e_1_2_13_128_1
  doi: 10.18632/oncotarget.21170
– ident: e_1_2_13_190_1
  doi: 10.1146/annurev-biophys-083012-130338
– ident: e_1_2_13_87_1
  doi: 10.2174/1874467214666210120153348
– ident: e_1_2_13_290_1
  doi: 10.18632/aging.202291
– ident: e_1_2_13_11_1
  doi: 10.2174/1566524020666200521080953
– ident: e_1_2_13_223_1
  doi: 10.3892/or.2017.5453
– ident: e_1_2_13_12_1
  doi: 10.1080/2162402x.2017.1423170
– volume: 14
  start-page: 617
  issue: 5
  year: 2001
  ident: e_1_2_13_210_1
  article-title: Responses of epithelial and fibroblast‐like cells to discontinuous configuration of the culture substrate
  publication-title: Membrane & Cell Biology
– ident: e_1_2_13_134_1
  doi: 10.1111/jcmm.17017
– ident: e_1_2_13_236_1
  doi: 10.1155/2019/9241769
– ident: e_1_2_13_265_1
  doi: 10.1002/ijc.31605
– ident: e_1_2_13_145_1
  doi: 10.1002/jcb.27738
– ident: e_1_2_13_17_1
  doi: 10.1016/j.carbpol.2021.117809
– ident: e_1_2_13_255_1
  doi: 10.3892/ijmm.2018.3788
– ident: e_1_2_13_221_1
  doi: 10.1002/ijc.26120
– ident: e_1_2_13_207_1
  doi: 10.3390/ijms21145164
– ident: e_1_2_13_42_1
  doi: 10.3390/biomedicines9080870
– ident: e_1_2_13_219_1
  doi: 10.3389/fphar.2018.01294
– volume: 11
  start-page: 479
  issue: 2
  year: 2021
  ident: e_1_2_13_285_1
  article-title: Elevated HMGB1 expression induced by hepatitis B virus X protein promotes epithelial‐mesenchymal transition and angiogenesis through STAT3/miR‐34a/NF‐κB in primary liver cancer
  publication-title: American Journal of Cancer Research
– ident: e_1_2_13_163_1
  doi: 10.1093/carcin/bgy178
– ident: e_1_2_13_246_1
  doi: 10.1002/1878-0261.12623
– ident: e_1_2_13_157_1
  doi: 10.1158/1078-0432.Ccr-11-2470
– ident: e_1_2_13_49_1
  doi: 10.7150/ijbs.39582
– ident: e_1_2_13_209_1
  doi: 10.1186/s12943-017-0688-6
– ident: e_1_2_13_70_1
  doi: 10.1186/s12885-019-5945-1
– ident: e_1_2_13_118_1
  doi: 10.1038/s41419-021-04346-8
– ident: e_1_2_13_151_1
  doi: 10.1007/s11033-021-06268-2
– ident: e_1_2_13_156_1
  doi: 10.1007/s00109-013-1095-0
– ident: e_1_2_13_248_1
  doi: 10.1007/s12079-019-00522-w
– ident: e_1_2_13_15_1
  doi: 10.3390/biom10071040
– ident: e_1_2_13_205_1
  doi: 10.3390/cancers10120481
– ident: e_1_2_13_164_1
  doi: 10.1016/j.cellsig.2021.110088
– ident: e_1_2_13_183_1
  doi: 10.3389/fonc.2018.00042
– ident: e_1_2_13_283_1
  doi: 10.1371/journal.pone.0158529
– volume: 11
  start-page: 3812
  issue: 7
  year: 2018
  ident: e_1_2_13_48_1
  article-title: microRNA‐340 influences cell proliferation, apoptosis and invasion by targeting NF‐κB1 in gastric cancer
  publication-title: International Journal of Clinical and Experimental Pathology
– ident: e_1_2_13_227_1
  doi: 10.1016/j.lfs.2020.118372
– ident: e_1_2_13_213_1
  doi: 10.1002/ijc.22657
– ident: e_1_2_13_175_1
  doi: 10.1017/erm.2021.15
– ident: e_1_2_13_266_1
  doi: 10.1016/j.bbrc.2018.08.005
– ident: e_1_2_13_58_1
  doi: 10.1016/j.bcp.2010.07.045
– ident: e_1_2_13_200_1
  doi: 10.1016/j.semcancer.2016.03.002
– ident: e_1_2_13_206_1
  doi: 10.1111/jcmm.16079
– ident: e_1_2_13_212_1
  doi: 10.3390/cancers13010130
– ident: e_1_2_13_217_1
  doi: 10.1007/978-0-387-89520-8_3
– ident: e_1_2_13_288_1
  doi: 10.1016/j.yexcr.2019.111785
– ident: e_1_2_13_249_1
  doi: 10.1016/j.lfs.2019.117167
– ident: e_1_2_13_27_1
  doi: 10.2174/1568009621666210203110305
– ident: e_1_2_13_158_1
  doi: 10.1016/j.canlet.2015.03.033
– ident: e_1_2_13_20_1
  doi: 10.1016/j.carbpol.2021.118491
– ident: e_1_2_13_50_1
  doi: 10.3892/mmr.2021.12261
– ident: e_1_2_13_68_1
  doi: 10.3892/or.2017.5369
– ident: e_1_2_13_270_1
  doi: 10.1038/s41467-018-05644-0
– ident: e_1_2_13_60_1
  doi: 10.1016/j.molmed.2016.03.002
– ident: e_1_2_13_51_1
  doi: 10.3390/biom10010066
– ident: e_1_2_13_182_1
  doi: 10.4149/bll_2020_005
– ident: e_1_2_13_21_1
  doi: 10.1016/j.biopha.2021.111824
– ident: e_1_2_13_103_1
  doi: 10.1038/s41467-019-13082-9
– ident: e_1_2_13_45_1
  doi: 10.1097/cad.0000000000001022
– ident: e_1_2_13_91_1
  doi: 10.1002/ctm2.233
– ident: e_1_2_13_148_1
  doi: 10.21873/anticanres.14757
– ident: e_1_2_13_7_1
  doi: 10.1002/ijc.23745
– ident: e_1_2_13_63_1
  doi: 10.2147/jhc.S336858
– ident: e_1_2_13_84_1
  doi: 10.1016/j.phrs.2019.104327
SSID ssj0009933
Score 2.6679802
SecondaryResourceType review_article
Snippet Metastasis of tumor cells is a complex challenge and significantly diminishes the overall survival and prognosis of cancer patients. The...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 2770
SubjectTerms Breast
Cancer
cancer therapy
chemoresistance
Chemotherapy
Drug resistance
EMT
Gastric cancer
Growth factors
Invasiveness
Medical prognosis
Mesenchyme
Metastases
Metastasis
NF‐κB signaling
Nuclear transport
Translocation
Tumor cells
Tumors
Vimentin
Title NF‐κB as a regulator of cancer metastasis and therapy response: A focus on epithelial–mesenchymal transition
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjcp.30759
https://www.ncbi.nlm.nih.gov/pubmed/35561232
https://www.proquest.com/docview/2688543735
https://www.proquest.com/docview/2664795533
Volume 237
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtQwEB5VlZC48NPys1CQQQhxSbtrx04Cp6ViVVWiQohKPSBFtuOoQDcpm-xhOfURkHgbHoKH6JMwYyepyo-EuFnJRHacGc_Ymfk-gCdcWIwbElr9xnEUx9xiy8hoUpapTBIiS6Jq5NcHau8w3j-SR2vwoq-FCfgQw4EbWYZfr8nAtWl2LkBDP1rcsKPDo-I9ytWigOjtBXRU1tHI-xQEGU96VKEx3xmevOyLfgswL8er3uHMrsP7fqghz-TT9rI12_bLLyiO__kuN-BaF4iyadCcm7Dmqg3YnFa4CZ-v2FPmU0P9mfsGXAmMlatN-HwwOz_7-uP7S6YbptkiMNnXC1aXzJICLdjctRpDzuYDClQFCwVeKxT1ybjuOZuysrbLhtUVc6dUEnKCNnB-9m1OhVD2eDXHYbXkQn022S04nL16t7sXdawNkRVSZJFKXCbSopQTEwtV8jJzGV0zRax5lqoisQLX1ERn3Jmi5MR6pieucFJlRqNPvQ3rVV25u8A07o24U2NnFaHEC21tYpShZEiCQBUjeNZ_v9x2kObErHGSBzBmnuPE5n5iR_B4ED0NOB5_EtrqlSDvTLnJuUpTSQBQcgSPhttohPRnRVeuXpKMipNMYug8gjtBeYZehCcgFRwH61Xg793n-7tvfOPev4veh6ucCjJ8AvEWrLeLpXuAYVJrHnp7-AnR9A9N
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3bbtQwEB2VIgQvXFouCwUMAsRL2l07dtZIPCwtq-1thVAr9S04jsOtm5RNVig89ROQ-A2-gH-Aj-iX4HEuVblIvPSBtygZxZY9Mx7bM-cAPKBM27ghQO_X9T3fp9o-RdzrJUmfBwGSJWE18vZYjHb9jT2-Nwdfm1qYCh-iPXBDy3D-Gg0cD6RXjlFD32m7Y7crnqxTKjdN-dFu2PKn62t2dh9SOny-szryak4BTzPOpCcCI1k_Tngv8plIaCKNxHdR7Csq-yIONLMWHyhJTRQnFDm5VM_EhgsZKevx7X_PwFlkEEek_rWXx2BVsiaud0kP3O81OEZdutJ29eTq91tIezJCdkvc8BJ8bwanymx5vzwromX96RfcyP9l9C7DxTrWJoPKOK7AnEkXYHGQqiKblOQRcdmv7lphAc5VpJzlInwYD48OP__49oyonCgyNa-R4SybkiwhGm1kSiamUDaqzt9agTQmVQ1baUVdvrF5QgYkyfQsJ1lKzAFWvexbMz86_DLBWi_9ppzYbhUYJbiEuauweyrDcA3m0yw1N4Aou_2jRnSNFgiEz5TWQSQizPdElFfWgceNwoS6Rm1H8pD9sMKbpqGdyNBNZAfut6IHFVTJn4SWGq0La2-Vh1T0-xwxrngH7rWfrZ_ByyOVmmyGMsIPJLe7gw5cr7S1bYU5jlVGbWedzv29-XBj9YV7uPnvonfh_GhneyvcWh9v3oILFOtPXL70EswX05m5baPCIrrjjJHAq9PW35_Fb26-
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3bbtQwEB2VIhAvXFouCwUMAsRL2l07dtZIPCxdVr3AqkJU6ltwHIdbN1k2WaHw1E9A4jP4A74B8RH9EjzOpSoXiZc-8GYlo9iyZ8bjeOYcgHuUaRs3BOj9ur7n-1TbVsS9XpL0eRAgWRJWIz8fi41df2uP7y3A16YWpsKHaH-4oWU4f40GPo2TtSPQ0HfaHtjthifrjMptU36057X88ebQLu59SkdPX65veDWlgKcZZ9ITgZGsHye8F_lMJDSRRuKzKPYVlX0RB5pZgw-UpCaKE4qUXKpnYsOFjJR1-Pa7p-C0L7oSeSKGL46wqmTNW-9yHrjfa2CMunStHerxze-3iPZ4gOx2uNEF-N7MTZXY8n51XkSr-tMvsJH_yeRdhPN1pE0GlWlcggWTLsHyIFVFNinJA-JyX92lwhKcqSg5y2X4MB4dHnz-8e0JUTlRZGZeI79ZNiNZQjRayIxMTKFsTJ2_tQJpTKoKttKKumxj84gMSJLpeU6ylJgp1rzsWyM_PPgywUov_aac2GEVGCO4dLnLsHsi03AFFtMsNdeAKHv4o0Z0jRYIg8-U1kEkIsz2RIxX1oGHjb6EusZsR-qQ_bBCm6ahXcjQLWQH7rai0wqo5E9CK43ShbWvykMq-n2OCFe8A3fa19bL4NWRSk02RxnhB5Lbs0EHrlbK2vbCHMMqo3awTuX-3n24tb7jGtf_XfQ2nN0ZjsJnm-PtG3COYvGJS5ZegcViNjc3bUhYRLecKRJ4ddLq-xMBJm1t
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=NF%E2%80%90%CE%BAB+as+a+regulator+of+cancer+metastasis+and+therapy+response%3A+A+focus+on+epithelial%E2%80%93mesenchymal+transition&rft.jtitle=Journal+of+cellular+physiology&rft.au=Mirzaei%2C+Sepideh&rft.au=Saghari%2C+Sam&rft.au=Bassiri%2C+Farzaneh&rft.au=Raesi%2C+Rasoul&rft.date=2022-07-01&rft.issn=0021-9541&rft.eissn=1097-4652&rft.volume=237&rft.issue=7&rft.spage=2770&rft.epage=2795&rft_id=info:doi/10.1002%2Fjcp.30759&rft.externalDBID=10.1002%252Fjcp.30759&rft.externalDocID=JCP30759
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-9541&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-9541&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-9541&client=summon